<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
   <front>
      <journal-meta>
         <journal-id journal-id-type="publisher-id">STD</journal-id>
         <journal-id journal-id-type="hwp">spstd</journal-id>
         <journal-title>International Journal of STD &amp; AIDS</journal-title>
         <issn pub-type="ppub">0956-4624</issn>
         <issn pub-type="epub">1758-1052</issn>
         <publisher>
            <publisher-name>SAGE Publications</publisher-name>
            <publisher-loc>Sage UK: London, England</publisher-loc>
         </publisher>
      </journal-meta>
      <article-meta>
         <article-id pub-id-type="doi">10.1177/0956462412472291</article-id>
         <article-id pub-id-type="publisher-id">10.1177_0956462412472291</article-id>
         <article-categories>
            <subj-group subj-group-type="heading">
               <subject>Original research articles</subject>
            </subj-group>
         </article-categories>
         <title-group>
            <article-title>Modelling the impact of HIV prevention and treatment for men who have sex with men on HIV epidemic trajectories in low- and middle-income countries</article-title>
         </title-group>
         <contrib-group>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Wirtz</surname>
                  <given-names>A L</given-names>
               </name>
               <degrees>MHS</degrees>
               <xref ref-type="aff" rid="af1">*</xref>
               <xref ref-type="aff" rid="af6">∥</xref>
               <xref ref-type="corresp" rid="cor1"/>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Walker</surname>
                  <given-names>D G</given-names>
               </name>
               <degrees>PhD, MSc</degrees>
               <xref ref-type="aff" rid="af2">†</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Bollinger</surname>
                  <given-names>L</given-names>
               </name>
               <degrees>PhD, MSc</degrees>
               <xref ref-type="aff" rid="af3">‡</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Sifakis</surname>
                  <given-names>F</given-names>
               </name>
               <degrees>PhD</degrees>
               <xref ref-type="aff" rid="af1">*</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Baral</surname>
                  <given-names>S</given-names>
               </name>
               <degrees>MD, MPH</degrees>
               <xref ref-type="aff" rid="af1">*</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Johns</surname>
                  <given-names>B</given-names>
               </name>
               <xref ref-type="aff" rid="af4">§</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Oelrichs</surname>
                  <given-names>R</given-names>
               </name>
               <degrees>PhD, MPH</degrees>
               <xref ref-type="aff" rid="af5">**</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Beyrer</surname>
                  <given-names>C</given-names>
               </name>
               <degrees>MD, MPH</degrees>
               <xref ref-type="aff" rid="af1">*</xref>
            </contrib>
         </contrib-group>
         <aff id="af1">
            <label>*</label>
            <institution xlink:type="simple">Center for Public Health and Human Rights, Johns Hopkins Bloomberg School of Public Health</institution>, <addr-line>615 N. Wolfe Street E 71443, Baltimore, MD21205</addr-line>
         </aff>
         <aff id="af6">
            <label>∥</label>
            <institution xlink:type="simple">Department of Emergency Medicine, Johns Hopkins Medical Institute</institution>, <addr-line>Baltimore, MD</addr-line>
         </aff>
         <aff id="af2">
            <label>†</label>
            <institution xlink:type="simple">Bill and Melinda Gates Foundation</institution>, <addr-line>Seattle, WA</addr-line>
         </aff>
         <aff id="af3">
            <label>‡</label>
            <institution xlink:type="simple">Futures Institute</institution>, <addr-line>Glastonbury, CT</addr-line>
         </aff>
         <aff id="af4">
            <label>§</label>
            <institution xlink:type="simple">Department of International Health, Johns Hopkins Bloomberg School of Public Health</institution>, <addr-line>Baltimore, MD</addr-line>
         </aff>
         <aff id="af5">
            <label>**</label>
            <institution xlink:type="simple">The World Bank</institution>, <addr-line>Washington, DC</addr-line>, <country>USA</country>
         </aff>
         <author-notes>
            <corresp id="cor1">
               <bold>Correspondence to:</bold> A Wirtz, <institution xlink:type="simple">Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health</institution>, <addr-line>615 N. Wolfe St. E 71443, Baltimore, MD 21205</addr-line>, <country>USA</country> Email: <email xlink:type="simple">awirtz@jhsph.edu</email>
            </corresp>
         </author-notes>
         <pub-date pub-type="epub-ppub">
            <month>1</month>
            <year>2013</year>
         </pub-date>
         <volume>24</volume>
         <issue>1</issue>
         <fpage>18</fpage>
         <lpage>30</lpage>
         <history>
            <date date-type="accepted">
               <day>5</day>
               <month>8</month>
               <year>2012</year>
            </date>
         </history>
         <permissions>
            <copyright-statement>© SAGE Publications Ltd, 2013</copyright-statement>
            <copyright-year>2013</copyright-year>
            <copyright-holder content-type="sage">SAGE Publications</copyright-holder>
         </permissions>
         <abstract>
            <p>Little is known about the impact of combination HIV prevention interventions for men who have sex with men (MSM) and the impacts on the wider epidemics. Modelling analyses of MSM-specific interventions across varied HIV epidemics may inform evidence-based responses. The Goals model was adapted to project the impacts of providing HIV interventions for MSM and access to expanded coverage of antiretroviral therapy (ART) for adults to measure the effects on the MSM and adult epidemics in Peru, Ukraine, Kenya and Thailand. Positive impacts were observed in all four countries. Across epidemics, 14–25% of infections among MSM may be averted between 2012 and 2016 when MSM interventions are brought to scale and MSM have equal access to expanded ART for adults. Among adults, MSM interventions may avert up to 4000 new infections, in addition to the benefits associated with increased ART. Greatest impacts from expanded interventions were observed in countries where same sex transmission contributes significantly to the HIV epidemic. While significant benefits are observed among the adult and MSM populations with expansion of ART, consideration should be given to the synergies of combining ART expansion with targeted interventions to reach hidden, high-risk populations for HIV testing and counselling and linkages to care.</p>
         </abstract>
         <kwd-group>
            <title>Keywords</title>
            <kwd>HIV</kwd>
            <kwd>AIDS</kwd>
            <kwd>homosexuality</kwd>
            <kwd>MSM</kwd>
            <kwd>HIV infection</kwd>
            <kwd>Goals model</kwd>
            <kwd>transmission</kwd>
            <kwd>prevention</kwd>
         </kwd-group>
      </article-meta>
   </front>
   <body>
      <sec id="s1" sec-type="intro">
         <title>INTRODUCTION</title>
         <p>The HIV epidemics among men who have sex with men (MSM) have received growing attention from researchers and medical communities, donors and political stakeholders. Baral and colleagues’ systematic review of HIV prevalence data reported by low- and middle-income countries (LMICs) from 2000 to 2006 demonstrated a markedly higher risk for HIV among MSM when compared with the general population, with a pooled odds ratio (OR) of 19.3 (95% confidence interval [CI] 18.8 to 19.8) across all countries when comparing MSM to all reproductive age adult males. HIV risks were 33 times greater for MSM in the Americas (OR 33.3, 95% CI 32.3 to 34.2), 19 times greater for MSM in Asia (OR 18.7, 95% CI 17.7 to 19.7) and four times for MSM in Africa (OR 3.8, 95% CI 3.3 to 4.3) compared with other men.<sup>
               <xref ref-type="bibr" rid="IJSA-12-005C1">1</xref>
            </sup> Responses have varied across countries; ranging from countries where stakeholders have actively sought to understand and increase prevention strategies to respond to the epidemic among MSM compared to other countries where response is challenged by a lack of data and/or sociopolitical issues that inhibit care seeking. Same-sex behaviour among men remains criminalized in over 30 LMICs globally, including approximately half of the countries in Africa, and is punishable by death in at least four countries.<sup>
               <xref ref-type="bibr" rid="IJSA-12-005C2">2</xref>
            </sup> Stigma in countries where same sex practices have been decriminalized still inhibits MSM from seeking HIV-related care or prevention services. These barriers compromise and limit understanding of HIV epidemics among MSM and, hence, of the wider populations with which they interact.</p>
         <p>We recently reported on emerging MSM epidemics, developing a method to classify HIV epidemic scenarios among MSM and to incorporate the concepts of concentrated or generalized epidemics in a more distinctive approach that is inclusive of MSM and other at-risk groups.<sup>
               <xref ref-type="bibr" rid="IJSA-12-005C3">3</xref>
            </sup> These scenarios situate MSM transmission within wider epidemic contexts. Based on a systematic review of the existing data we found that HIV epidemics in LMICs could be described with four country scenarios: (1) the predominant mode of transmission of HIV cases is related to MSM anal sex transmission; (2) HIV transmission among MSM occurs in the context of injecting drug use (IDU) epidemics; (3) HIV transmission among MSM occurs in the context of widespread and generalized HIV transmission among heterosexuals; and (4) MSM, heterosexual and parenteral modes of transmission all contribute to HIV spread.<sup>
               <xref ref-type="bibr" rid="IJSA-12-005C3">3</xref>
            </sup> These epidemic scenarios allow for more nuanced understandings of the interplay of transmission related to MSM and the other components of the HIV epidemics that exist at population levels. Acknowledging, for example, that some MSM may also inject drugs or that in many epidemic contexts a majority of MSM may be married to women and acquisition and transmission risks, therefore, exist for both MSM and women.</p>
         <p>Evidence-based responses to prevent HIV transmission among MSM require an understanding of the impacts of interventions available for MSM. Through clinical and outreach services, interventions can be provided to MSM for individual prevention of HIV transmission and acquisition. Limited data on population-level impacts with HIV endpoints exist for these interventions for MSM. Mathematical models can fill this gap to inform national and local programming by estimating the impacts of alternative combinations of interventions. We used the Goals model to assess the impact of combinations of HIV prevention interventions and antiretroviral therapy (ART) treatment access and uptake for MSM on overall country-level HIV epidemic scenarios, through 2016, represented by Peru, Ukraine, Kenya and Thailand.</p>
      </sec>
      <sec id="s2" sec-type="methods">
         <title>METHODS</title>
         <sec id="s2a">
            <title>Modification of Goals</title>
            <p>The Goals model was adapted and used to estimate HIV incidence, with and without one or more interventions delivered at different levels of coverage. The Goals model (Spectrum software, Futures Institute, Glastonbury, CT, USA) is a deterministic model that uses data in three main areas to project new HIV infections: demography, sexual behaviour and HIV/sexually transmitted infection (STI) epidemiology.<sup>
                  <xref ref-type="bibr" rid="IJSA-12-005C4">4</xref>
               </sup> Prior to this effort, Goals considered five different risk groups in the general population: MSM, IDU, high-risk heterosexuals, medium-risk heterosexuals and low-risk heterosexuals. Recognizing that risk may vary among MSM as well, we adapted the Goals model within the Spectrum software to allow for the input of epidemiological data relating to four MSM risk categories (Table <xref ref-type="table" rid="IJSA-12-005TB1">1</xref>). The MSM risk categories were defined as high-risk MSM or male sex workers, medium risk or MSM with more than one sex partner in last 12 months, low-risk MSM or men with 0–1 male sex partner in last 12 months (stable relationship) and MSM IDU or MSM who also inject drugs. Further details of the Goals model are available in the appendix or the Goals manual.<sup>
                  <xref ref-type="bibr" rid="IJSA-12-005C5">5</xref>
               </sup>
               <table-wrap id="IJSA-12-005TB1" position="float">
                  <label>Table 1</label>
                  <caption>
                     <p>Major updates to the Goals model and rationale</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                     <colgroup span="1">
                        <col align="left" span="1"/>
                        <col align="left" span="1"/>
                     </colgroup>
                     <tbody>
                        <tr>
                           <td align="left" colspan="1" rowspan="1">Addition of MSM risk categories</td>
                           <td align="left" colspan="1" rowspan="1">Based on literature reviews followed by expert and community group review and consensus
<list list-type="bullet">
                                 <list-item>
                                    <p>
                                       <italic>High-risk MSM</italic>: male sex workers</p>
                                 </list-item>
                                 <list-item>
                                    <p>
                                       <italic>Medium risk</italic>: MSM with more than one sex partner in last 12 months</p>
                                 </list-item>
                                 <list-item>
                                    <p>
                                       <italic>Low-risk MSM</italic>: men with 0–1 male sex partner in last 12 months (stable relationship)</p>
                                 </list-item>
                                 <list-item>
                                    <p>
                                       <italic>MSM-IDU</italic>: MSM who also inject drugs</p>
                                 </list-item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="1" rowspan="1">Addition of MSM-specific interventions and impacts</td>
                           <td colspan="1" rowspan="1">Based on systematic review of literature and analysis for interventions impacts
<list list-type="bullet">
                                 <list-item>
                                    <p>
                                       <italic>Individual level</italic> with promotion and distribution of condoms and water-based lubricants (acknowledging that water-based lubricants must be provided with condoms to maintain condom efficacy)</p>
                                 </list-item>
                                 <list-item>
                                    <p>
                                       <italic>Community-level behavioural change</italic> interventions based on evidence of higher efficacy of community over individual level interventions for MSM<sup>
                                          <xref ref-type="bibr" rid="IJSA-12-005C1">1</xref>
                                       </sup>
                                    </p>
                                 </list-item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="1" rowspan="1">Epidemiological inputs: infectiousness when on ART</td>
                           <td colspan="1" rowspan="1">Based on the most recent finding reported by Eshleman and colleagues who reported an 86% reduction in HIV transmission after ARV treatment was initiated in discordant couples</td>
                        </tr>
                     </tbody>
                  </table>
                  <table-wrap-foot>
                     <fn>
                        <p>MSM = men who have sex with men; ARV = antiretroviral</p>
                     </fn>
                  </table-wrap-foot>
               </table-wrap>
            </p>
            <p>The Goals model was further adapted to include selected MSM-specific interventions with evidence for efficacy. These included promotion and distribution of condoms with water-based lubricants; community-level behavioural change interventions which include HIV counselling and testing (selected over individual level behavioural change as a recent Cochrane review showed higher efficacy of community over individual level interventions for MSM<sup>
                  <xref ref-type="bibr" rid="IJSA-12-005C6">6</xref>
               </sup>); and earlier initiation of ART (Table <xref ref-type="table" rid="IJSA-12-005TB1">1</xref>).<sup>
                  <xref ref-type="bibr" rid="IJSA-12-005C7">7</xref>,<xref ref-type="bibr" rid="IJSA-12-005C8">8</xref>
               </sup>
            </p>
         </sec>
         <sec id="s2b">
            <title>Selection of countries and inputs for Goals</title>
            <p>Four countries with HIV prevalence and transmission risk data for MSM were selected, each representing an epidemic scenario. MSM specific data for each country were collected through a systematic review (methods previously published in Beyrer <italic>et al.</italic>
               <sup>
                  <xref ref-type="bibr" rid="IJSA-12-005C3">3</xref>
               </sup>) and augmented by communications with country experts and review of gray literature and country reports. Key data used to parameterize the Goals model are presented in Table <xref ref-type="table" rid="IJSA-12-005TB2">2</xref> and described briefly below. Once parameterized, the Goals models were calibrated to the median UNAIDS estimations for the prevalence of HIV infection among the adult population and fit to within 95% CIs around the recent projected UNAIDS estimates (unpublished). The HIV prevalence trends among MSM that were estimated by the models were cross-checked against surveillance or other published estimates of HIV prevalence among MSM in each country.<sup>
                  <xref ref-type="bibr" rid="IJSA-12-005C9">9</xref>–<xref ref-type="bibr" rid="IJSA-12-005C19">19</xref>
               </sup>
               <table-wrap id="IJSA-12-005TB2" position="float">
                  <label>Table 2</label>
                  <caption>
                     <p>Epidemiological assumptions and behavioural inputs and sources per MSM risk category for each country model</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                     <colgroup span="1">
                        <col align="left" span="1"/>
                        <col align="left" span="1"/>
                        <col align="left" span="1"/>
                        <col align="left" span="1"/>
                        <col align="left" span="1"/>
                        <col align="left" span="1"/>
                        <col align="left" span="1"/>
                        <col align="left" span="1"/>
                        <col align="left" span="1"/>
                        <col align="left" span="1"/>
                        <col align="left" span="1"/>
                        <col align="left" span="1"/>
                        <col align="left" span="1"/>
                        <col align="left" span="1"/>
                        <col align="left" span="1"/>
                        <col align="left" span="1"/>
                        <col align="left" span="1"/>
                     </colgroup>
                     <thead>
                        <tr>
                           <th colspan="1" rowspan="1"/>
                           <th align="left" colspan="4" rowspan="1">Ukraine</th>
                           <th align="left" colspan="4" rowspan="1">Kenya</th>
                           <th align="left" colspan="4" rowspan="1">Peru</th>
                           <th align="left" colspan="4" rowspan="1">Thailand</th>
                        </tr>
                        <tr>
                           <th colspan="1" rowspan="1"/>
                           <th align="left" colspan="1" rowspan="1">Low</th>
                           <th align="left" colspan="1" rowspan="1">Med</th>
                           <th align="left" colspan="1" rowspan="1">High</th>
                           <th align="left" colspan="1" rowspan="1">MSM-IDU</th>
                           <th align="left" colspan="1" rowspan="1">Low</th>
                           <th align="left" colspan="1" rowspan="1">Med</th>
                           <th align="left" colspan="1" rowspan="1">High</th>
                           <th align="left" colspan="1" rowspan="1">MSM-IDU</th>
                           <th align="left" colspan="1" rowspan="1">Low</th>
                           <th align="left" colspan="1" rowspan="1">Med</th>
                           <th align="left" colspan="1" rowspan="1">High</th>
                           <th align="left" colspan="1" rowspan="1">MSM-IDU</th>
                           <th align="left" colspan="1" rowspan="1">Low</th>
                           <th align="left" colspan="1" rowspan="1">Med</th>
                           <th align="left" colspan="1" rowspan="1">High</th>
                           <th align="left" colspan="1" rowspan="1">MSM-IDU</th>
                        </tr>
                     </thead>
                     <tbody>
                        <tr>
                           <td colspan="17" rowspan="1">
                              <bold>Proportion of adult male population</bold>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="1" rowspan="1"> Value in model (%)</td>
                           <td colspan="1" rowspan="1">0.41</td>
                           <td colspan="1" rowspan="1">1.40</td>
                           <td colspan="1" rowspan="1">0.55</td>
                           <td colspan="1" rowspan="1">0.15</td>
                           <td colspan="1" rowspan="1">0.53</td>
                           <td colspan="1" rowspan="1">2.01</td>
                           <td colspan="1" rowspan="1">0.42</td>
                           <td colspan="1" rowspan="1">0.4</td>
                           <td colspan="1" rowspan="1">0.62</td>
                           <td colspan="1" rowspan="1">1.86</td>
                           <td colspan="1" rowspan="1">0.91</td>
                           <td colspan="1" rowspan="1">N/A</td>
                           <td colspan="1" rowspan="1">0.68</td>
                           <td colspan="1" rowspan="1">1.78</td>
                           <td colspan="1" rowspan="1">0.59</td>
                           <td colspan="1" rowspan="1">0.35</td>
                        </tr>
                        <tr>
                           <td colspan="1" rowspan="1"> Reference(s) for estimates</td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C2">2</xref>,<xref ref-type="bibr" rid="IJSA-12-005C3">3</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C2">2</xref>,<xref ref-type="bibr" rid="IJSA-12-005C3">3</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C3">3</xref>,<xref ref-type="bibr" rid="IJSA-12-005C4">4</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C3">3</xref>,<xref ref-type="bibr" rid="IJSA-12-005C5">5</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C3">3</xref>,<xref ref-type="bibr" rid="IJSA-12-005C6">6</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C3">3</xref>,<xref ref-type="bibr" rid="IJSA-12-005C6">6</xref>,<xref ref-type="bibr" rid="IJSA-12-005C7">7</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C3">3</xref>,<xref ref-type="bibr" rid="IJSA-12-005C8">8</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C3">3</xref>,<xref ref-type="bibr" rid="IJSA-12-005C8">8</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C3">3</xref>,<xref ref-type="bibr" rid="IJSA-12-005C9">9</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C3">3</xref>,<xref ref-type="bibr" rid="IJSA-12-005C9">9</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C3">3</xref>,<xref ref-type="bibr" rid="IJSA-12-005C9">9</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C3">3</xref>,<xref ref-type="bibr" rid="IJSA-12-005C9">9</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C3">3</xref>,<xref ref-type="bibr" rid="IJSA-12-005C10">10</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C3">3</xref>,<xref ref-type="bibr" rid="IJSA-12-005C10">10</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C3">3</xref>,<xref ref-type="bibr" rid="IJSA-12-005C11">11</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C3">3</xref>,<xref ref-type="bibr" rid="IJSA-12-005C12">12</xref>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="17" rowspan="1">
                              <bold>HIV Prevalence among MSM</bold>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="1" rowspan="1"> Value in model (%)</td>
                           <td colspan="1" rowspan="1">N/D</td>
                           <td colspan="1" rowspan="1">10.6*</td>
                           <td colspan="1" rowspan="1">16.0</td>
                           <td colspan="1" rowspan="1">43.0</td>
                           <td colspan="1" rowspan="1">N/D</td>
                           <td colspan="1" rowspan="1">24.8</td>
                           <td colspan="1" rowspan="1">16.7</td>
                           <td colspan="1" rowspan="1">N/D</td>
                           <td colspan="1" rowspan="1">20.2</td>
                           <td colspan="1" rowspan="1">23</td>
                           <td colspan="1" rowspan="1">25.2</td>
                           <td colspan="1" rowspan="1">N/A</td>
                           <td colspan="1" rowspan="1">N/D</td>
                           <td colspan="1" rowspan="1">19.2</td>
                           <td colspan="1" rowspan="1">15.6</td>
                           <td colspan="1" rowspan="1">31.8</td>
                        </tr>
                        <tr>
                           <td colspan="1" rowspan="1"> Reference(s)</td>
                           <td colspan="1" rowspan="1"/>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C5">5</xref>,<xref ref-type="bibr" rid="IJSA-12-005C13">13</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C14">14</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C15">15</xref>
                           </td>
                           <td colspan="1" rowspan="1"/>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C16">16</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C7">7</xref>,<xref ref-type="bibr" rid="IJSA-12-005C16">16</xref>
                           </td>
                           <td colspan="1" rowspan="1"/>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C9">9</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C9">9</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C9">9</xref>
                           </td>
                           <td colspan="1" rowspan="1"/>
                           <td colspan="1" rowspan="1"/>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C10">10</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C10">10</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C12">12</xref>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="17" rowspan="1">
                              <bold>Ulcerative STI prevalence among MSM</bold>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="1" rowspan="1"> Value in model (%)</td>
                           <td colspan="1" rowspan="1">10.5<sup>†</sup>
                           </td>
                           <td colspan="1" rowspan="1">10.5</td>
                           <td colspan="1" rowspan="1">12.0</td>
                           <td colspan="1" rowspan="1">10.5<sup>†</sup>
                           </td>
                           <td colspan="1" rowspan="1"/>
                           <td colspan="1" rowspan="1">31.8</td>
                           <td colspan="1" rowspan="1">19.7</td>
                           <td colspan="1" rowspan="1">N/D</td>
                           <td colspan="1" rowspan="1">7.0</td>
                           <td colspan="1" rowspan="1">15.0</td>
                           <td colspan="1" rowspan="1">20.0</td>
                           <td colspan="1" rowspan="1">N/A</td>
                           <td colspan="1" rowspan="1">7.0</td>
                           <td colspan="1" rowspan="1">7.0</td>
                           <td colspan="1" rowspan="1">7.0</td>
                           <td colspan="1" rowspan="1">7.0</td>
                        </tr>
                        <tr>
                           <td colspan="1" rowspan="1"> Reference(s)</td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C17">17</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C17">17</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C14">14</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C17">17</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C16">16</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C16">16</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C16">16</xref>
                           </td>
                           <td colspan="1" rowspan="1"/>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C9">9</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C9">9</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C9">9</xref>
                           </td>
                           <td colspan="1" rowspan="1"/>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C18">18</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C18">18</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C18">18</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C18">18</xref>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="17" rowspan="1">
                              <bold>Percent married</bold>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="1" rowspan="1"> Value in model (%)</td>
                           <td colspan="1" rowspan="1">10.3</td>
                           <td colspan="1" rowspan="1">10.3</td>
                           <td colspan="1" rowspan="1">10.3</td>
                           <td colspan="1" rowspan="1">10.3</td>
                           <td colspan="1" rowspan="1">0</td>
                           <td colspan="1" rowspan="1">12.4</td>
                           <td colspan="1" rowspan="1">4.5</td>
                           <td colspan="1" rowspan="1">N/D</td>
                           <td colspan="1" rowspan="1">1.6</td>
                           <td colspan="1" rowspan="1">9.5</td>
                           <td colspan="1" rowspan="1">9.5</td>
                           <td colspan="1" rowspan="1">N/A</td>
                           <td colspan="1" rowspan="1">14.1</td>
                           <td colspan="1" rowspan="1">14.1</td>
                           <td colspan="1" rowspan="1">14.1</td>
                           <td colspan="1" rowspan="1">24.2</td>
                        </tr>
                        <tr>
                           <td colspan="1" rowspan="1"> Reference(s)</td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C2">2</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C2">2</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C2">2</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C2">2</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C16">16</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C16">16</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C16">16</xref>
                           </td>
                           <td colspan="1" rowspan="1"/>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C9">9</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C9">9</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C9">9</xref>
                           </td>
                           <td colspan="1" rowspan="1"/>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C19">19</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C19">19</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C19">19</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C19">19</xref>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="17" rowspan="1">
                              <bold>Consistent condom use (adjustment factor – 33% for use at last contact)</bold>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="1" rowspan="1"> Value in model (%)</td>
                           <td colspan="1" rowspan="1">25.0</td>
                           <td colspan="1" rowspan="1">27.1</td>
                           <td colspan="1" rowspan="1">26.5</td>
                           <td colspan="1" rowspan="1">27.1</td>
                           <td colspan="1" rowspan="1">25.0</td>
                           <td colspan="1" rowspan="1">38.6</td>
                           <td colspan="1" rowspan="1">32.1</td>
                           <td colspan="1" rowspan="1">N/D</td>
                           <td colspan="1" rowspan="1">16.0</td>
                           <td colspan="1" rowspan="1">28.0</td>
                           <td colspan="1" rowspan="1">42.0</td>
                           <td colspan="1" rowspan="1">N/A</td>
                           <td colspan="1" rowspan="1">15.0</td>
                           <td colspan="1" rowspan="1">45.0</td>
                           <td colspan="1" rowspan="1">80.0</td>
                           <td colspan="1" rowspan="1">45.0</td>
                        </tr>
                        <tr>
                           <td colspan="1" rowspan="1"> Reference(s)</td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C2">2</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C2">2</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C2">2</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C2">2</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C7">7</xref>,<xref ref-type="bibr" rid="IJSA-12-005C16">16</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C7">7</xref>,<xref ref-type="bibr" rid="IJSA-12-005C16">16</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C7">7</xref>,<xref ref-type="bibr" rid="IJSA-12-005C16">16</xref>
                           </td>
                           <td colspan="1" rowspan="1"/>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C9">9</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C9">9</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C9">9</xref>
                           </td>
                           <td colspan="1" rowspan="1"/>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C19">19</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C10">10</xref>,<xref ref-type="bibr" rid="IJSA-12-005C19">19</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C19">19</xref>,<xref ref-type="bibr" rid="IJSA-12-005C20">20</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C12">12</xref>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="17" rowspan="1">
                              <bold>Mean sexual partners per year</bold>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="1" rowspan="1"> Value in model</td>
                           <td colspan="1" rowspan="1">1</td>
                           <td colspan="1" rowspan="1">4</td>
                           <td colspan="1" rowspan="1">12</td>
                           <td colspan="1" rowspan="1">4<sup>†</sup>
                           </td>
                           <td colspan="1" rowspan="1">1</td>
                           <td colspan="1" rowspan="1">3</td>
                           <td colspan="1" rowspan="1">20</td>
                           <td colspan="1" rowspan="1">N/D</td>
                           <td colspan="1" rowspan="1">1</td>
                           <td colspan="1" rowspan="1">3</td>
                           <td colspan="1" rowspan="1">20</td>
                           <td colspan="1" rowspan="1">N/A</td>
                           <td colspan="1" rowspan="1">1</td>
                           <td colspan="1" rowspan="1">4.7</td>
                           <td colspan="1" rowspan="1">28</td>
                           <td colspan="1" rowspan="1">15</td>
                        </tr>
                        <tr>
                           <td colspan="1" rowspan="1"> Reference(s)</td>
                           <td colspan="1" rowspan="1">
                              <italic>t</italic>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C2">2</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C21">21</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C2">2</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <italic>t</italic>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C16">16</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C16">16</xref>
                           </td>
                           <td colspan="1" rowspan="1"/>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C9">9</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C9">9</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C9">9</xref>
                           </td>
                           <td colspan="1" rowspan="1"/>
                           <td colspan="1" rowspan="1">
                              <italic>t</italic>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C22">22</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C22">22</xref>
                           </td>
                           <td colspan="1" rowspan="1">
                              <xref ref-type="bibr" rid="IJSA-12-005C19">19</xref>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <table-wrap-foot>
                     <fn>
                        <p>MSM = men who have sex with men; STI = sexually transmitted infection</p>
                     </fn>
                     <fn>
                        <p>*Pooled HIV prevalence used for all risk groups in the absence of group-specific data</p>
                     </fn>
                     <fn>
                        <p>
                           <sup>†</sup>Medium-risk group estimates used as a proxy when low or MSM-IDU data are unavailable; <italic>t</italic> number of partners by definition of low risk group; N/D = no data; N/A = not applicable</p>
                     </fn>
                  </table-wrap-foot>
               </table-wrap>
            </p>
            <p>Scenario 1 countries, where MSM transmission predominantly contributes to the HIV epidemic, were represented by Peru. General population prevalence data and projected ART coverage estimates were available from DemProj and AIM of the Spectrum suite, as well as behavioural inputs, and intervention coverage among the general population. Personal communication with research experts from Peru (Konda and Caceres CC, personal communication) provided data specific to the MSM population, and a 2009 paper by Aldridge and colleagues,<sup>
                  <xref ref-type="bibr" rid="IJSA-12-005C20">20</xref>
               </sup> who conducted similar modelling work using an Excel version of the Goals model, was used to supplement any missing information and confirm inputs.</p>
            <p>Scenario 2 countries, where HIV transmission among MSM occurs in the context of IDU epidemics, were represented by Ukraine. General population data and ART-projected coverage were populated using data available in DemProj and AIM of the Spectrum suite and further updated with UNAIDS and Alliance reports;<sup>
                  <xref ref-type="bibr" rid="IJSA-12-005C12">12</xref>,<xref ref-type="bibr" rid="IJSA-12-005C21">21</xref>,<xref ref-type="bibr" rid="IJSA-12-005C22">22</xref>
               </sup> HIV and STI prevalence of HIV among IDU and MSM and behavioural data were derived from UNGASS reports<sup>
                  <xref ref-type="bibr" rid="IJSA-12-005C21">21</xref>
               </sup> and published papers; and<sup>
                  <xref ref-type="bibr" rid="IJSA-12-005C9">9</xref>,<xref ref-type="bibr" rid="IJSA-12-005C10">10</xref>,<xref ref-type="bibr" rid="IJSA-12-005C23">23</xref>
               </sup> data from Russia were used as a proxy for behavioural and epidemiological data specific to the MSM IDU category.<sup>
                  <xref ref-type="bibr" rid="IJSA-12-005C24">24</xref>–<xref ref-type="bibr" rid="IJSA-12-005C30">30</xref>
               </sup>
            </p>
            <p>Scenario 3 countries, where HIV transmission among MSM occurs in the context of well-established HIV transmission among heterosexuals, were represented by Kenya. General prevalence data and ART-projected coverage were provided from DemProj and AIM of the Spectrum suite, population prevalence of MSM were calculated using data from peer-reviewed publications;<sup>
                  <xref ref-type="bibr" rid="IJSA-12-005C15">15</xref>,<xref ref-type="bibr" rid="IJSA-12-005C31">31</xref>
               </sup> prevalence of HIV and STI and MSM behavioural data were provided by experts from the Kenya Medical Research Institute (KEMRI, unpublished); and coverage of MSM specific interventions were obtained from UNGASS/MoH reports.<sup>
                  <xref ref-type="bibr" rid="IJSA-12-005C13">13</xref>,<xref ref-type="bibr" rid="IJSA-12-005C32">32</xref>,<xref ref-type="bibr" rid="IJSA-12-005C33">33</xref>
               </sup>
            </p>
            <p>Scenario 4 countries, where both sexual and parenteral modes of transmission contribute significantly to HIV transmission, were represented by Thailand. General population data, including incidence and prevalence trends and national projections for ART coverage, were populated using data available in DemProj and AIM of the Spectrum suite. IDU and MSM epidemiological and behavioural data were collected with assistance from the Bangkok MSM Cohort research experts from data published in the Asian Epidemic Model<sup>
                  <xref ref-type="bibr" rid="IJSA-12-005C34">34</xref>
               </sup> and other publications from the CDC, the Thai Red Cross, Thailand's Ministry of Public Health and other regional experts.<sup>
                  <xref ref-type="bibr" rid="IJSA-12-005C11">11</xref>,<xref ref-type="bibr" rid="IJSA-12-005C18">18</xref>,<xref ref-type="bibr" rid="IJSA-12-005C19">19</xref>,<xref ref-type="bibr" rid="IJSA-12-005C35">35</xref>–<xref ref-type="bibr" rid="IJSA-12-005C38">38</xref>
               </sup> Intervention coverage estimates were obtained from UNGASS/MoH reports<sup>
                  <xref ref-type="bibr" rid="IJSA-12-005C39">39</xref>
               </sup> and expert opinion.</p>
            <p>For all country models, we updated infectiousness when on ART with the finding reported by Eshleman <italic>et al.</italic>
               <sup>
                  <xref ref-type="bibr" rid="IJSA-12-005C8">8</xref>
               </sup> that demonstrated reduction in HIV transmission after ART treatment was initiated in discordant couples. Given the importance of recent findings from the HPTN 052 study, we modelled the impact of earlier initiation of treatment among all adults in need of ART, according to the recent change in standards.<sup>
                  <xref ref-type="bibr" rid="IJSA-12-005C40">40</xref>
               </sup> These models utilized an initiation of ART at a CD4 count of 350 cells/mm<sup>3</sup> and the demonstrated effectiveness value of 88.6% reduction in risk associated with ART at this initiation.<sup>
                  <xref ref-type="bibr" rid="IJSA-12-005C8">8</xref>
               </sup> For this study, we used a slightly conservative estimate of 87% (0.13 reduction in transmission when on ART).</p>
            <p>The behavioural intervention impact matrix used in the Goals model records the impact of exposure to a prevention intervention on the reduction in non-use of condoms and the reduction in number of partners per risk group (See Goals Description, Appendix, for further details).<sup>
                  <xref ref-type="bibr" rid="IJSA-12-005C4">4</xref>
               </sup> Because two new MSM interventions were added, the impacts of exposure to MSM prevention interventions were derived through the systematic review of HIV prevention interventions for MSM.<sup>
                  <xref ref-type="bibr" rid="IJSA-12-005C3">3</xref>,<xref ref-type="bibr" rid="IJSA-12-005C41">41</xref>
               </sup> The results of these reviews were then used to develop summary estimates of the reductions of condom non-use (unprotected anal intercourse) and reduction in number of partners, stratified for each MSM risk group (Table <xref ref-type="table" rid="IJSA-12-005TB3">3</xref>). These estimates provided the data for the impacts of the MSM specific interventions.
<table-wrap id="IJSA-12-005TB3" position="float">
                  <label>Table 3</label>
                  <caption>
                     <p>Country intervention coverage: baseline 2011 coverage levels and expansion scenarios used for projections</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                     <colgroup span="1">
                        <col align="left" span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                     </colgroup>
                     <thead>
                        <tr>
                           <th colspan="1" rowspan="1"/>
                           <th align="left" colspan="3" rowspan="1">Outreach for MSM</th>
                           <th align="left" colspan="3" rowspan="1">Condoms and lubricants for MSM</th>
                           <th colspan="1" rowspan="1"/>
                           <th colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                           <th colspan="1" rowspan="1"/>
                           <th colspan="1" rowspan="1"/>
                           <th align="left" colspan="1" rowspan="1">Scenario 1</th>
                           <th align="left" colspan="1" rowspan="1">Scenario 2</th>
                           <th colspan="1" rowspan="1"/>
                           <th align="left" colspan="1" rowspan="1">Scenario 1</th>
                           <th align="left" colspan="1" rowspan="1">Scenario 2</th>
                           <th align="left" colspan="2" rowspan="1">ART for all adults who meet criteria</th>
                        </tr>
                        <tr>
                           <th align="left" colspan="1" rowspan="1">Country of interest</th>
                           <th align="left" colspan="1" rowspan="1">Status quo</th>
                           <th align="left" colspan="1" rowspan="1">+20% of status quo</th>
                           <th align="left" colspan="1" rowspan="1">+40% of status quo</th>
                           <th align="left" colspan="1" rowspan="1">Status quo</th>
                           <th align="left" colspan="1" rowspan="1">+20% of status quo</th>
                           <th align="left" colspan="1" rowspan="1">+40% of status quo</th>
                           <th align="left" colspan="1" rowspan="1">Status quo (2011)</th>
                           <th align="left" colspan="1" rowspan="1">Expanded (2016)</th>
                        </tr>
                     </thead>
                     <tbody>
                        <tr>
                           <td colspan="1" rowspan="1">Peru</td>
                           <td colspan="1" rowspan="1">21%<sup>
                                 <xref ref-type="bibr" rid="IJSA-12-005C23">23</xref>
                              </sup>
                           </td>
                           <td colspan="1" rowspan="1">41%</td>
                           <td colspan="1" rowspan="1">61%</td>
                           <td colspan="1" rowspan="1">45%<sup>
                                 <xref ref-type="bibr" rid="IJSA-12-005C23">23</xref>
                              </sup>
                           </td>
                           <td colspan="1" rowspan="1">65%</td>
                           <td colspan="1" rowspan="1">85%</td>
                           <td colspan="1" rowspan="1">43%</td>
                           <td colspan="1" rowspan="1">57%</td>
                        </tr>
                        <tr>
                           <td colspan="1" rowspan="1">Ukraine</td>
                           <td colspan="1" rowspan="1">33%<sup>
                                 <xref ref-type="bibr" rid="IJSA-12-005C5">5</xref>
                              </sup>
                           </td>
                           <td colspan="1" rowspan="1">53%</td>
                           <td colspan="1" rowspan="1">73%</td>
                           <td colspan="1" rowspan="1">40%<sup>
                                 <xref ref-type="bibr" rid="IJSA-12-005C5">5</xref>
                              </sup>
                           </td>
                           <td colspan="1" rowspan="1">60%</td>
                           <td colspan="1" rowspan="1">80%</td>
                           <td colspan="1" rowspan="1">12%</td>
                           <td colspan="1" rowspan="1">24%</td>
                        </tr>
                        <tr>
                           <td colspan="1" rowspan="1">Kenya</td>
                           <td colspan="1" rowspan="1">15%<sup>
                                 <xref ref-type="bibr" rid="IJSA-12-005C7">7</xref>
                              </sup>
                           </td>
                           <td colspan="1" rowspan="1">35%</td>
                           <td colspan="1" rowspan="1">55%</td>
                           <td colspan="1" rowspan="1">5%<sup>
                                 <xref ref-type="bibr" rid="IJSA-12-005C16">16</xref>
                              </sup>
                           </td>
                           <td colspan="1" rowspan="1">25%</td>
                           <td colspan="1" rowspan="1">45%</td>
                           <td colspan="1" rowspan="1">63%</td>
                           <td colspan="1" rowspan="1">85%</td>
                        </tr>
                        <tr>
                           <td colspan="1" rowspan="1">Thailand</td>
                           <td colspan="1" rowspan="1">20%<sup>
                                 <xref ref-type="bibr" rid="IJSA-12-005C24">24</xref>
                              </sup>
                           </td>
                           <td colspan="1" rowspan="1">40%</td>
                           <td colspan="1" rowspan="1">60%</td>
                           <td colspan="1" rowspan="1">20%<sup>
                                 <xref ref-type="bibr" rid="IJSA-12-005C24">24</xref>
                              </sup>
                           </td>
                           <td colspan="1" rowspan="1">40%</td>
                           <td colspan="1" rowspan="1">60%</td>
                           <td colspan="1" rowspan="1">53%</td>
                           <td colspan="1" rowspan="1">59%</td>
                        </tr>
                     </tbody>
                  </table>
                  <table-wrap-foot>
                     <fn>
                        <p>MSM = men who have sex with men; ART = antiretroviral therapy</p>
                     </fn>
                  </table-wrap-foot>
               </table-wrap>
            </p>
         </sec>
         <sec id="s2c">
            <title>Estimating the fraction of HIV transmission attributable to MSM</title>
            <p>To understand how MSM transmission is situated within each country's epidemic, we estimated the total fraction of new HIV-positive cases attributable to same sex behaviour of MSM. This was estimated through a calculation nested within the overall Goals model analysis of each of the case countries. The baseline number of new HIV infections was estimated using the ‘current intervention scenario’ of each country, in which no additional coverage of existing or new interventions is added to what is currently in place in 2011. Coverage levels from 2011 were selected as most data and reports were available from this year and provided the most coverage information for all four selected countries. The number of new HIV infections attributable to MSM is then calculated as a residual by subtracting the number of new HIV infections <italic>not</italic> attributable to MSM from the total number of new HIV infections. To estimate the number of new HIV infections <italic>not</italic> attributable to MSM, the HIV transmission probability for MSM was assumed to be zero, and the number of new HIV infections was then calculated. The numerator was calculated as the number of new HIV cases not attributed to MSM subtracted from the total number of new HIV cases; the denominator was the number of total new HIV cases. The percentage is presented for year 2016 for each case country to understand how the epidemic would progress without further expansion of intervention coverage.</p>
         </sec>
         <sec id="s2d">
            <title>Projections of MSM intervention scenarios</title>
            <p>The impact of MSM focused interventions on the HIV epidemic can be assessed by varying levels of intervention coverage among MSM and coverage of ART among the adult population, including and assuming equitable distribution to MSM in need of treatment. Estimated coverage levels of each intervention modelled are detailed in Table <xref ref-type="table" rid="IJSA-12-005TB3">3</xref>. The modelled scenarios include (1) Status quo: current coverage of MSM-specific prevention interventions are maintained from 2011 to 2016 while all other interventions remain constant. (2) Scenario 1: all MSM interventions increase from current, 2011 levels incrementally to reach an additional 20% by 2016 (coverage changes from 2012 to 2016), while all interventions are held constant from 2011 levels. (3) Scenario 2: MSM interventions increase from current, 2011 levels incrementally to reach an additional 40% by 2016 (coverage changes from 2012 to 2016), while all interventions are held constant from 2011 levels.</p>
            <p>All three scenarios were analysed with ART coverage of the adult population held constant from 2011 levels forward. The scenarios were then replicated with the planned expansion of ART among the adult population. These scenarios assume that the increase in ART coverage among adults applies to MSM as well as other adult risk groups, and also assumes a supportive environment in which MSM interventions are fully provided and HIV-positive MSM have full access to HIV counselling and testing and ART. We investigate the impacts of increased coverage of MSM interventions and ART expansion among adults on new infections among the MSM population from 2012 to 2016. We investigate the combined impacts and the impacts that are attributable to the increased coverage of the MSM interventions. We also investigate the impacts on the new infections among the adult population that are attributable to expansion of the MSM interventions, in the environments of either maintained or expanded ART.</p>
            <p>Sensitivity analyses were conducted to assess the uncertainty surrounding the impact coefficients for the disaggregated MSM groups. These analyses were performed using upper and lower bounds of impacts of optimal intervention scenario for MSM-specific interventions (Table <xref ref-type="table" rid="IJSA-12-005TB4">4</xref>) and sensitivity analyses were conducted for second scenario that included ART coverage among the adult population. The results are presented as the percent reduction in new infections among MSM, compared with the status quo estimates without expansion of ART.
<table-wrap id="IJSA-12-005TB4" position="float">
                  <label>Table 4</label>
                  <caption>
                     <p>Transmission impacts of MSM-specific interventions on condom use and number of partners per MSM risk categories: results of a systematic review for inputs to the Goals impact matrix</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                     <colgroup span="1">
                        <col align="left" span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="left" span="1"/>
                        <col align="left" span="1"/>
                     </colgroup>
                     <thead>
                        <tr>
                           <th colspan="1" rowspan="1"/>
                           <th align="left" colspan="3" rowspan="1">Reduction in condom non-use</th>
                           <th align="left" colspan="3" rowspan="1">Reduction in number of partners</th>
                        </tr>
                        <tr>
                           <th colspan="1" rowspan="1"/>
                           <th align="left" colspan="1" rowspan="1">High-risk MSM</th>
                           <th align="left" colspan="1" rowspan="1">Medium-risk MSM</th>
                           <th align="left" colspan="1" rowspan="1">Low-risk MSM</th>
                           <th align="left" colspan="1" rowspan="1">High-risk MSM</th>
                           <th align="left" colspan="1" rowspan="1">Medium-risk MSM</th>
                           <th align="left" colspan="1" rowspan="1">Low-risk MSM</th>
                        </tr>
                        <tr>
                           <th align="left" colspan="1" rowspan="1">Intervention</th>
                           <th align="left" colspan="1" rowspan="1">% reduction (range)</th>
                           <th align="left" colspan="1" rowspan="1">% reduction (range)</th>
                           <th align="left" colspan="1" rowspan="1">% reduction (range)</th>
                           <th align="left" colspan="1" rowspan="1">% reduction (range)</th>
                           <th align="left" colspan="1" rowspan="1">% reduction (range)</th>
                           <th align="left" colspan="1" rowspan="1">% reduction (range)</th>
                        </tr>
                     </thead>
                     <tbody>
                        <tr>
                           <td colspan="1" rowspan="1">Community-based outreach</td>
                           <td colspan="1" rowspan="1">−19.6</td>
                           <td colspan="1" rowspan="1">−19.6</td>
                           <td colspan="1" rowspan="1">−19.6</td>
                           <td colspan="1" rowspan="1">−19.0</td>
                           <td colspan="1" rowspan="1">−19.0</td>
                           <td colspan="1" rowspan="1">−19.0</td>
                        </tr>
                        <tr>
                           <td colspan="1" rowspan="1"/>
                           <td colspan="1" rowspan="1">(−8.1 to −29.9)</td>
                           <td colspan="1" rowspan="1">(−8.1 to −29.9)</td>
                           <td colspan="1" rowspan="1">(−8.1 to −29.9)</td>
                           <td colspan="1" rowspan="1">(−0.7 to −25.0)</td>
                           <td colspan="1" rowspan="1">(−0.7 to −25.0)</td>
                           <td colspan="1" rowspan="1">(−0.7 to −25.0)</td>
                        </tr>
                        <tr>
                           <td colspan="1" rowspan="1">Individual with condoms and lubricants</td>
                           <td colspan="1" rowspan="1">−22.8</td>
                           <td colspan="1" rowspan="1">−17.4</td>
                           <td colspan="1" rowspan="1">−6.9</td>
                           <td colspan="1" rowspan="1">−18.3</td>
                           <td colspan="1" rowspan="1">−0.8</td>
                           <td colspan="1" rowspan="1">0.0</td>
                        </tr>
                        <tr>
                           <td colspan="1" rowspan="1"/>
                           <td colspan="1" rowspan="1">(−0.6 to −26.0)</td>
                           <td colspan="1" rowspan="1">(−2.0 to −58.8)</td>
                           <td colspan="1" rowspan="1">(−4.0 to −9.0)</td>
                           <td colspan="1" rowspan="1">(−1.1 to −25.0)</td>
                           <td colspan="1" rowspan="1">(0 to −3.8)</td>
                           <td colspan="1" rowspan="1">0.0</td>
                        </tr>
                     </tbody>
                  </table>
                  <table-wrap-foot>
                     <fn>
                        <p>MSM = men who have sex with men</p>
                     </fn>
                     <fn>
                        <p>Source: Systematic review of HIV prevention interventions for MSM<sup>
                              <xref ref-type="bibr" rid="IJSA-12-005C20">20</xref>
                           </sup>
                        </p>
                     </fn>
                  </table-wrap-foot>
               </table-wrap>
            </p>
         </sec>
      </sec>
      <sec id="s3" sec-type="results">
         <title>RESULTS</title>
         <p>The proportion of new HIV cases attributed to male anal sex transmission from 2012 through 2016 varies across the four countries when coverage levels were held constant (data not displayed). Figure <xref ref-type="fig" rid="IJSA-12-005F1">1</xref> shows the fraction of new HIV cases attributed to MSM by 2016. Ongoing MSM incidence would contribute to 8% of new infections in Kenya, to a high of 96.3% of new infections in Peru, by 2016. The attributable fraction of transmission related to MSM is increasing in Peru and, to a lesser degree, in Thailand. The prevalence of HIV among IDUs and sex workers in Thailand and Ukraine may account for a significant proportion of the remaining 53% and 80% of HIV that is attributed to other modes of transmission, respectively. Finally, the attributable fraction of HIV infections related to MSM may be increasing in Kenya. Estimating these proportions allows us to account for behaviour and transmission between MSM and bridging with other populations (e.g. MSM who inject drugs and female sex partners of bisexual men).
<fig id="IJSA-12-005F1" position="float">
               <label>Figure 1</label>
               <caption>
                  <p>Attributable fraction of new HIV infections from MSM behaviour in selected countries by 2016. MSM = men who have sex with men</p>
               </caption>
               <graphic position="float" xlink:href="10.1177_0956462412472291-fig1.tif" xlink:type="simple"/>
            </fig>
         </p>
         <p>Figures <xref ref-type="fig" rid="IJSA-12-005F2">2</xref>–<xref ref-type="fig" rid="IJSA-12-005F5">5</xref> display the modelled impact of the interventions on new infections among MSM. Figure <xref ref-type="fig" rid="IJSA-12-005F6">6</xref> displays the sensitivity analysis around the maximal intervention – increasing coverage of MSM interventions by 40% by 2016 and allowing equal access to expanded ART for MSM – compared with a status quo scenario in which there is no increase in coverage of MSM interventions or ART. The error bars display the high and low values of the sensitivity analysis of the impact matrix. Tables <xref ref-type="table" rid="IJSA-12-005TB5">5</xref>–<xref ref-type="table" rid="IJSA-12-005TB8">8</xref> depict the numbers of new HIV infections among adults for each country stratified by intervention combination without and with ART expansion among the adult populations.
<fig id="IJSA-12-005F2" position="float">
               <label>Figure 2</label>
               <caption>
                  <p>Trajectories of the estimated number of new HIV infections among MSM in Peru with implementation of three intervention scenarios for MSM without (a) and with ART expansion among the adult population (b) (2011–2016). <italic>y</italic>-Axes do not start at zero new infections for the purpose of ensuring differences in new infections are visible over time. MSM = men who have sex with men; ART = antiretroviral therapy</p>
               </caption>
               <graphic position="float" xlink:href="10.1177_0956462412472291-fig2.tif" xlink:type="simple"/>
            </fig>
            <fig id="IJSA-12-005F3" position="float">
               <label>Figure 3</label>
               <caption>
                  <p>Trajectories of the estimated number of new HIV infections in Ukraine with implementation of three intervention scenarios for MSM without (a) and with ART expansion among the adult population (b) (2011–2016). <italic>y</italic>-Axes do not start at zero new infections for the purpose of ensuring differences in new infections are visible over time. MSM = men who have sex with men; ART = antiretroviral therapy</p>
               </caption>
               <graphic position="float" xlink:href="10.1177_0956462412472291-fig3.tif" xlink:type="simple"/>
            </fig>
            <fig id="IJSA-12-005F4" position="float">
               <label>Figure 4</label>
               <caption>
                  <p>Trajectories of the estimated number of new HIV infections in Kenya with implementation of three intervention scenarios for MSM without (a) and with ART expansion among the adult population (b) (2011–2016). <italic>y</italic>-Axes do not start at zero new infections for the purpose of ensuring differences in new infections are visible over time. MSM = men who have sex with men; ART = antiretroviral therapy</p>
               </caption>
               <graphic position="float" xlink:href="10.1177_0956462412472291-fig4.tif" xlink:type="simple"/>
            </fig>
            <fig id="IJSA-12-005F5" position="float">
               <label>Figure 5</label>
               <caption>
                  <p>Trajectories of the estimated number of new HIV infections in Thailand implementation of three intervention scenarios for MSM without (a) and with ART expansion among the adult population (b) (2011–2016). <italic>y</italic>-Axes do not start at zero new infections for the purpose of ensuring differences in new infections are visible over time. MSM = men who have sex with men; ART = antiretroviral therapy</p>
               </caption>
               <graphic position="float" xlink:href="10.1177_0956462412472291-fig5.tif" xlink:type="simple"/>
            </fig>
            <fig id="IJSA-12-005F6" position="float">
               <label>Figure 6</label>
               <caption>
                  <p>Sensitivity analysis of reduction in new infections among MSM with increased coverage of interventions for MSM and equal access to expanded ART, 2012–2016. MSM = men who have sex with men; ART = antiretroviral therapy</p>
               </caption>
               <graphic position="float" xlink:href="10.1177_0956462412472291-fig6.tif" xlink:type="simple"/>
            </fig>
            <table-wrap id="IJSA-12-005TB5" position="float">
               <label>Table 5</label>
               <caption>
                  <p>Projected estimates of the number of new adult HIV infections in Peru with implementation of three intervention scenarios for MSM (2011–2016)</p>
               </caption>
               <table frame="hsides" rules="groups">
                  <colgroup span="1">
                     <col align="left" span="1"/>
                     <col align="left" span="1"/>
                     <col align="left" span="1"/>
                     <col align="left" span="1"/>
                     <col align="left" span="1"/>
                     <col align="left" span="1"/>
                     <col align="left" span="1"/>
                  </colgroup>
                  <thead>
                     <tr>
                        <th colspan="1" rowspan="1"/>
                        <th align="left" colspan="1" rowspan="1">Status quo</th>
                        <th align="left" colspan="1" rowspan="1">Scenario 1</th>
                        <th align="left" colspan="1" rowspan="1">Scenario 2</th>
                        <th align="left" colspan="1" rowspan="1">Status quo</th>
                        <th align="left" colspan="1" rowspan="1">Scenario 1</th>
                        <th align="left" colspan="1" rowspan="1">Scenario 2</th>
                     </tr>
                     <tr>
                        <th colspan="1" rowspan="1"/>
                        <th align="left" colspan="3" rowspan="1">(without expansion of ART)</th>
                        <th align="left" colspan="3" rowspan="1">(with expansion of ART)</th>
                     </tr>
                  </thead>
                  <tbody>
                     <tr>
                        <td colspan="1" rowspan="1">2011</td>
                        <td colspan="1" rowspan="1">6583</td>
                        <td colspan="1" rowspan="1">6583</td>
                        <td colspan="1" rowspan="1">6583</td>
                        <td colspan="1" rowspan="1">6666</td>
                        <td colspan="1" rowspan="1">6666</td>
                        <td colspan="1" rowspan="1">6666</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">2012</td>
                        <td colspan="1" rowspan="1">6636</td>
                        <td colspan="1" rowspan="1">6542</td>
                        <td colspan="1" rowspan="1">6450</td>
                        <td colspan="1" rowspan="1">6494</td>
                        <td colspan="1" rowspan="1">6402</td>
                        <td colspan="1" rowspan="1">6312</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">2013</td>
                        <td colspan="1" rowspan="1">6710</td>
                        <td colspan="1" rowspan="1">6517</td>
                        <td colspan="1" rowspan="1">6329</td>
                        <td colspan="1" rowspan="1">6310</td>
                        <td colspan="1" rowspan="1">6126</td>
                        <td colspan="1" rowspan="1">5948</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">2014</td>
                        <td colspan="1" rowspan="1">6764</td>
                        <td colspan="1" rowspan="1">6469</td>
                        <td colspan="1" rowspan="1">6187</td>
                        <td colspan="1" rowspan="1">6122</td>
                        <td colspan="1" rowspan="1">5849</td>
                        <td colspan="1" rowspan="1">5589</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">2015</td>
                        <td colspan="1" rowspan="1">6798</td>
                        <td colspan="1" rowspan="1">6400</td>
                        <td colspan="1" rowspan="1">6026</td>
                        <td colspan="1" rowspan="1">5934</td>
                        <td colspan="1" rowspan="1">5573</td>
                        <td colspan="1" rowspan="1">5236</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">2016</td>
                        <td colspan="1" rowspan="1">6816</td>
                        <td colspan="1" rowspan="1">6313</td>
                        <td colspan="1" rowspan="1">5850</td>
                        <td colspan="1" rowspan="1">6038</td>
                        <td colspan="1" rowspan="1">5572</td>
                        <td colspan="1" rowspan="1">5146</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">
                           <bold>Cumulative</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>40,307</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>38,824</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>37,425</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>37,564</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>36,188</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>34,897</bold>
                        </td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">
                           <bold>% reduction</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>(ref)</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>3.7</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>7.2</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>(ref)</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>3.7</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>7.1</bold>
                        </td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">
                           <bold>Infections averted</bold>
                        </td>
                        <td colspan="1" rowspan="1"/>
                        <td colspan="1" rowspan="1">
                           <bold>1483</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>2882</bold>
                        </td>
                        <td colspan="1" rowspan="1"/>
                        <td colspan="1" rowspan="1">
                           <bold>1376</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>2667</bold>
                        </td>
                     </tr>
                  </tbody>
               </table>
               <table-wrap-foot>
                  <fn>
                     <p>MSM = men who have sex with men</p>
                  </fn>
               </table-wrap-foot>
            </table-wrap>
            <table-wrap id="IJSA-12-005TB6" position="float">
               <label>Table 6</label>
               <caption>
                  <p>Projected estimates of the number of new adult HIV infections in Ukraine with implementation of three intervention scenarios for MSM (2011–2016)</p>
               </caption>
               <table frame="hsides" rules="groups">
                  <colgroup span="1">
                     <col align="left" span="1"/>
                     <col align="left" span="1"/>
                     <col align="left" span="1"/>
                     <col align="left" span="1"/>
                     <col align="left" span="1"/>
                     <col align="left" span="1"/>
                     <col align="left" span="1"/>
                  </colgroup>
                  <thead>
                     <tr>
                        <th colspan="1" rowspan="1"/>
                        <th align="left" colspan="1" rowspan="1">Status quo</th>
                        <th align="left" colspan="1" rowspan="1">Scenario 1</th>
                        <th align="left" colspan="1" rowspan="1">Scenario 2</th>
                        <th align="left" colspan="1" rowspan="1">Status quo</th>
                        <th align="left" colspan="1" rowspan="1">Scenario 1</th>
                        <th align="left" colspan="1" rowspan="1">Scenario 2</th>
                     </tr>
                     <tr>
                        <th colspan="1" rowspan="1"/>
                        <th align="left" colspan="3" rowspan="1">(without expansion of ART)</th>
                        <th align="left" colspan="3" rowspan="1">(with expansion of ART)</th>
                     </tr>
                  </thead>
                  <tbody>
                     <tr>
                        <td colspan="1" rowspan="1">2011</td>
                        <td colspan="1" rowspan="1">45,589</td>
                        <td colspan="1" rowspan="1">45,589</td>
                        <td colspan="1" rowspan="1">45,589</td>
                        <td colspan="1" rowspan="1">45,589</td>
                        <td colspan="1" rowspan="1">45,589</td>
                        <td colspan="1" rowspan="1">45,589</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">2012</td>
                        <td colspan="1" rowspan="1">45,914</td>
                        <td colspan="1" rowspan="1">45,841</td>
                        <td colspan="1" rowspan="1">45,769</td>
                        <td colspan="1" rowspan="1">44,544</td>
                        <td colspan="1" rowspan="1">44,474</td>
                        <td colspan="1" rowspan="1">44,404</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">2013</td>
                        <td colspan="1" rowspan="1">46,001</td>
                        <td colspan="1" rowspan="1">45,859</td>
                        <td colspan="1" rowspan="1">45,720</td>
                        <td colspan="1" rowspan="1">43,530</td>
                        <td colspan="1" rowspan="1">43,395</td>
                        <td colspan="1" rowspan="1">43,264</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">2014</td>
                        <td colspan="1" rowspan="1">45,873</td>
                        <td colspan="1" rowspan="1">45,666</td>
                        <td colspan="1" rowspan="1">45,467</td>
                        <td colspan="1" rowspan="1">42,553</td>
                        <td colspan="1" rowspan="1">42,361</td>
                        <td colspan="1" rowspan="1">42,176</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">2015</td>
                        <td colspan="1" rowspan="1">45,596</td>
                        <td colspan="1" rowspan="1">45,328</td>
                        <td colspan="1" rowspan="1">45,075</td>
                        <td colspan="1" rowspan="1">41,513</td>
                        <td colspan="1" rowspan="1">41,269</td>
                        <td colspan="1" rowspan="1">41,039</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">2016</td>
                        <td colspan="1" rowspan="1">45,211</td>
                        <td colspan="1" rowspan="1">44,886</td>
                        <td colspan="1" rowspan="1">44,584</td>
                        <td colspan="1" rowspan="1">39,841</td>
                        <td colspan="1" rowspan="1">39,555</td>
                        <td colspan="1" rowspan="1">39,289</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">
                           <bold>Cumulative</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>274,184</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>273,169</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>272,204</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>257,570</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>256,643</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>255,761</bold>
                        </td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">
                           <bold>% reduction</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>(ref)</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>0.4</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>0.7</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>(ref)</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>0.4</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>0.7</bold>
                        </td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">
                           <bold>Infections averted</bold>
                        </td>
                        <td colspan="1" rowspan="1"/>
                        <td colspan="1" rowspan="1">
                           <bold>1015</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>1980</bold>
                        </td>
                        <td colspan="1" rowspan="1"/>
                        <td colspan="1" rowspan="1">
                           <bold>927</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>1809</bold>
                        </td>
                     </tr>
                  </tbody>
               </table>
               <table-wrap-foot>
                  <fn>
                     <p>MSM = men who have sex with men</p>
                  </fn>
               </table-wrap-foot>
            </table-wrap>
            <table-wrap id="IJSA-12-005TB7" position="float">
               <label>Table 7</label>
               <caption>
                  <p>Projected estimates of the number of new adult HIV infections in Kenya with implementation of three intervention scenarios for MSM (2011–2016)</p>
               </caption>
               <table frame="hsides" rules="groups">
                  <colgroup span="1">
                     <col align="left" span="1"/>
                     <col align="left" span="1"/>
                     <col align="left" span="1"/>
                     <col align="left" span="1"/>
                     <col align="left" span="1"/>
                     <col align="left" span="1"/>
                     <col align="left" span="1"/>
                  </colgroup>
                  <thead>
                     <tr>
                        <th colspan="1" rowspan="1"/>
                        <th align="left" colspan="1" rowspan="1">Status quo</th>
                        <th align="left" colspan="1" rowspan="1">Scenario 1</th>
                        <th align="left" colspan="1" rowspan="1">Scenario 2</th>
                        <th align="left" colspan="1" rowspan="1">Status quo</th>
                        <th align="left" colspan="1" rowspan="1">Scenario 1</th>
                        <th align="left" colspan="1" rowspan="1">Scenario 2</th>
                     </tr>
                     <tr>
                        <th colspan="1" rowspan="1"/>
                        <th align="left" colspan="3" rowspan="1">(without expansion of ART)</th>
                        <th align="left" colspan="3" rowspan="1">(with expansion of ART)</th>
                     </tr>
                  </thead>
                  <tbody>
                     <tr>
                        <td colspan="1" rowspan="1">2011</td>
                        <td colspan="1" rowspan="1">102,756</td>
                        <td colspan="1" rowspan="1">102,756</td>
                        <td colspan="1" rowspan="1">102,756</td>
                        <td colspan="1" rowspan="1">102,756</td>
                        <td colspan="1" rowspan="1">102,756</td>
                        <td colspan="1" rowspan="1">102,756</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">2012</td>
                        <td colspan="1" rowspan="1">103,347</td>
                        <td colspan="1" rowspan="1">103,213</td>
                        <td colspan="1" rowspan="1">103,081</td>
                        <td colspan="1" rowspan="1">92,435</td>
                        <td colspan="1" rowspan="1">92,312</td>
                        <td colspan="1" rowspan="1">92,191</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">2013</td>
                        <td colspan="1" rowspan="1">105,643</td>
                        <td colspan="1" rowspan="1">105,357</td>
                        <td colspan="1" rowspan="1">105,082</td>
                        <td colspan="1" rowspan="1">81,619</td>
                        <td colspan="1" rowspan="1">81,384</td>
                        <td colspan="1" rowspan="1">81,157</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">2014</td>
                        <td colspan="1" rowspan="1">108,160</td>
                        <td colspan="1" rowspan="1">107,715</td>
                        <td colspan="1" rowspan="1">107,294</td>
                        <td colspan="1" rowspan="1">75,500</td>
                        <td colspan="1" rowspan="1">75,159</td>
                        <td colspan="1" rowspan="1">74,839</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">2015</td>
                        <td colspan="1" rowspan="1">110,685</td>
                        <td colspan="1" rowspan="1">110,074</td>
                        <td colspan="1" rowspan="1">109,508</td>
                        <td colspan="1" rowspan="1">74,216</td>
                        <td colspan="1" rowspan="1">73,762</td>
                        <td colspan="1" rowspan="1">73,344</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">2016</td>
                        <td colspan="1" rowspan="1">113,120</td>
                        <td colspan="1" rowspan="1">112,337</td>
                        <td colspan="1" rowspan="1">111,630</td>
                        <td colspan="1" rowspan="1">72,504</td>
                        <td colspan="1" rowspan="1">71,939</td>
                        <td colspan="1" rowspan="1">71,432</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">
                           <bold>Cumulative</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>643,711</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>641,452</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>639,351</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>499,030</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>497,312</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>495,719</bold>
                        </td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">
                           <bold>% reduction</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>(ref)</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>0.4</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>0.7</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>(ref)</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>0.3</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>0.7</bold>
                        </td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">
                           <bold>Infections averted</bold>
                        </td>
                        <td colspan="1" rowspan="1"/>
                        <td colspan="1" rowspan="1">
                           <bold>2259</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>4360</bold>
                        </td>
                        <td colspan="1" rowspan="1"/>
                        <td colspan="1" rowspan="1">
                           <bold>1718</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>3311</bold>
                        </td>
                     </tr>
                  </tbody>
               </table>
               <table-wrap-foot>
                  <fn>
                     <p>MSM = men who have sex with men</p>
                  </fn>
               </table-wrap-foot>
            </table-wrap>
            <table-wrap id="IJSA-12-005TB8" position="float">
               <label>Table 8</label>
               <caption>
                  <p>Projected estimates of the number of new adult HIV infections in Thailand with implementation of three intervention scenarios for MSM (2011–2016)</p>
               </caption>
               <table frame="hsides" rules="groups">
                  <colgroup span="1">
                     <col align="left" span="1"/>
                     <col align="left" span="1"/>
                     <col align="left" span="1"/>
                     <col align="left" span="1"/>
                     <col align="left" span="1"/>
                     <col align="left" span="1"/>
                     <col align="left" span="1"/>
                  </colgroup>
                  <thead>
                     <tr>
                        <th colspan="1" rowspan="1"/>
                        <th align="left" colspan="1" rowspan="1">Status quo</th>
                        <th align="left" colspan="1" rowspan="1">Scenario 1</th>
                        <th align="left" colspan="1" rowspan="1">Scenario 2</th>
                        <th align="left" colspan="1" rowspan="1">Status quo</th>
                        <th align="left" colspan="1" rowspan="1">Scenario 1</th>
                        <th align="left" colspan="1" rowspan="1">Scenario 2</th>
                     </tr>
                     <tr>
                        <th colspan="1" rowspan="1"/>
                        <th align="left" colspan="3" rowspan="1">(without expansion of ART)</th>
                        <th align="left" colspan="3" rowspan="1">(with expansion of ART)</th>
                     </tr>
                  </thead>
                  <tbody>
                     <tr>
                        <td colspan="1" rowspan="1">2011</td>
                        <td colspan="1" rowspan="1">25,636</td>
                        <td colspan="1" rowspan="1">25,636</td>
                        <td colspan="1" rowspan="1">25,636</td>
                        <td colspan="1" rowspan="1">25,636</td>
                        <td colspan="1" rowspan="1">25,636</td>
                        <td colspan="1" rowspan="1">25,636</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">2012</td>
                        <td colspan="1" rowspan="1">25,342</td>
                        <td colspan="1" rowspan="1">25,178</td>
                        <td colspan="1" rowspan="1">25,016</td>
                        <td colspan="1" rowspan="1">22,653</td>
                        <td colspan="1" rowspan="1">22,503</td>
                        <td colspan="1" rowspan="1">22,356</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">2013</td>
                        <td colspan="1" rowspan="1">24,735</td>
                        <td colspan="1" rowspan="1">24,397</td>
                        <td colspan="1" rowspan="1">24,070</td>
                        <td colspan="1" rowspan="1">20,384</td>
                        <td colspan="1" rowspan="1">20,098</td>
                        <td colspan="1" rowspan="1">19,821</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">2014</td>
                        <td colspan="1" rowspan="1">23,927</td>
                        <td colspan="1" rowspan="1">23,416</td>
                        <td colspan="1" rowspan="1">22,929</td>
                        <td colspan="1" rowspan="1">18,816</td>
                        <td colspan="1" rowspan="1">18,400</td>
                        <td colspan="1" rowspan="1">18,004</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">2015</td>
                        <td colspan="1" rowspan="1">23,014</td>
                        <td colspan="1" rowspan="1">22,331</td>
                        <td colspan="1" rowspan="1">21,692</td>
                        <td colspan="1" rowspan="1">17,522</td>
                        <td colspan="1" rowspan="1">16,980</td>
                        <td colspan="1" rowspan="1">16,475</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">2016</td>
                        <td colspan="1" rowspan="1">22,063</td>
                        <td colspan="1" rowspan="1">21,208</td>
                        <td colspan="1" rowspan="1">20,425</td>
                        <td colspan="1" rowspan="1">16,255</td>
                        <td colspan="1" rowspan="1">15,595</td>
                        <td colspan="1" rowspan="1">14,993</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">
                           <bold>Cumulative</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>144,717</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>142,166</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>139,768</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>121,266</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>119,212</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>117,285</bold>
                        </td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">
                           <bold>% reduction</bold>
                        </td>
                        <td align="left" colspan="1" rowspan="1">
                           <bold>(ref)</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>1.8</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>3.4</bold>
                        </td>
                        <td align="left" colspan="1" rowspan="1">
                           <bold>(ref)</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>1.7</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>3.3</bold>
                        </td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">
                           <bold>Infections averted</bold>
                        </td>
                        <td colspan="1" rowspan="1"/>
                        <td colspan="1" rowspan="1">
                           <bold>2551</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>4949</bold>
                        </td>
                        <td colspan="1" rowspan="1"/>
                        <td colspan="1" rowspan="1">
                           <bold>2054</bold>
                        </td>
                        <td colspan="1" rowspan="1">
                           <bold>3981</bold>
                        </td>
                     </tr>
                  </tbody>
               </table>
               <table-wrap-foot>
                  <fn>
                     <p>MSM = men who have sex with men; ART = antiretroviral therapy</p>
                  </fn>
               </table-wrap-foot>
            </table-wrap>
         </p>
         <p>Projections from Peru show that much higher coverage of interventions for MSM will be needed to change the trajectory of the HIV epidemic among MSM in Peru, if ART is maintained at current coverage levels (Figure <xref ref-type="fig" rid="IJSA-12-005F2">2</xref>). Increasing MSM-specific interventions and providing HIV-positive MSM equal access to and treatment with ART may also lead to a 15% reduction in new infections (4600 averted) among MSM. Beyond ART, MSM interventions may avert 2600–2800 infections between 2012 and 2016, almost a 10% reduction in new infections among MSM. The expansion of MSM-specific interventions with and without additional expansion of ART for adults, may also contribute an additional 2700–2900 infections averted among the adult population (a reduction of 7%) within the five-year time span (Table <xref ref-type="table" rid="IJSA-12-005TB5">5</xref>).</p>
         <p>In Ukraine, increasing coverage of MSM-specific interventions demonstrates an impact on the HIV epidemic among the general population in later years and may avert between 1800 and 2000 new adult infections between 2012 and 2016, a 1% reduction in addition to the benefits observed with expansion of ART (Table <xref ref-type="table" rid="IJSA-12-005TB6">6</xref>). Among MSM, there is general decline in new infections; this decline is augmented by the expansion of ART and further enhanced through scale-up of MSM interventions (Figure <xref ref-type="fig" rid="IJSA-12-005F3">3</xref>). MSM interventions, with and without ART expansion, may lead to a cumulative 1400–1600 infections averted among MSM or a reduction of 8% within five years beyond benefits provided by ART. The combined effect of increasing MSM interventions and allowing equal access to expanded ART may lead to a 14% reduction in new infections, or 2700 infections averted, among MSM within five years.</p>
         <p>There has been a great expansion of ART among the adult population in Kenya and this expanded coverage is planned to continue into the future and, thus far, has provided obvious impact for the adult and MSM populations. The expansion of ART among adults also shows demonstrable impacts among the MSM population (Figure <xref ref-type="fig" rid="IJSA-12-005F4">4</xref>) and, in combination with the MSM interventions may result in a 25% reduction in new infections among MSM, or almost 10,000 infections averted within five years. MSM specific interventions may avert 3000 new MSM infections (9% reduction) over the five-year period, in addition to the benefits provided by ART. Almost 4000 new infections may be averted if ART does not increase beyond current coverage levels (10% reduction in new infections). MSM-specific interventions positively impact the general population in Kenya and, while relative impact may be modest, the numbers of infections averted are considerable averting almost 3300 new adult infections when ART is expanded and more (almost 4400) when ART coverage is maintained at 2011 levels (a reduction of approximately 1% of new infections) (Table <xref ref-type="table" rid="IJSA-12-005TB7">7</xref>).</p>
         <p>The epidemic projections of new infections in Thailand show an increase over time, particularly when MSM-specific interventions and ART coverage is maintained at 2011 levels. Like Peru, the increase in coverage of MSM-specific interventions could change the trajectory of the epidemic among MSM by 2016 compared (Figure <xref ref-type="fig" rid="IJSA-12-005F5">5</xref>). Among MSM, approximately 3600–4500 infections may be averted, a 9–10% reduction in new infections, by MSM interventions when they are scaled-up without and with expansion of ART coverage among adults. The combined impact of ART expansion and MSM interventions may result in a cumulative 10,300 infections averted, or a 22% reduction in new infections among MSM from 2012 to 2016. Among adults, in addition to the benefits observed with the expansion of ART, almost 4000–5000 new infections may be averted (3% reduction) within five years when MSM interventions are scaled up (Table <xref ref-type="table" rid="IJSA-12-005TB8">8</xref>).</p>
      </sec>
      <sec id="s4" sec-type="discussion">
         <title>DISCUSSION</title>
         <p>These modelling projections show the combined benefit for MSM of providing equal access to ART as it expands according to national strategies and increasing coverage of targeted MSM interventions. The greatest impacts among MSM that are associated with the combined access to ART and expanded MSM interventions are observed in Kenya and Thailand, likely a result of greater coverage of ART. The projections also demonstrate additional impact of MSM interventions among both the MSM and the general populations when such interventions are applied within epidemic scenarios. Greatest impacts of these MSM interventions on the adult epidemics are observed among countries such as Peru and Thailand, where the attributable fraction of HIV transmission is predominantly related to male same sex behaviour. While the percent reductions may appear to be low, likely due to the short five-year time frame of the projections, the absolute numbers of infections averted are significant and are likely to continue increasing as the interventions continue in the future.</p>
         <p>The attributable fraction can be used to allocate HIV prevention resources and target programmes on the basis of the contribution of risk groups to local HIV incidence; however, it is important that these estimates be examined in relation to all other risk groups contributing to the total number of HIV. Countries that have actively sought to understand the epidemic and prevent transmission among MSM within the overall epidemic scenario, such as Thailand and Peru, demonstrate benefits for MSM and the general population.<sup>
               <xref ref-type="bibr" rid="IJSA-12-005C42">42</xref>
            </sup> Even in countries where positive social changes are observed, research suggests that national health strategies need to follow and provide appropriate resources for prevention among MSM. Caceres’ work in Peru, for example, shows that despite evidence that HIV transmission occurs predominantly among MSM, the majority of funding has been allocated to prevention for other vulnerable populations among which the prevalence of HIV is lower than that observed among MSM.<sup>
               <xref ref-type="bibr" rid="IJSA-12-005C32">32</xref>,<xref ref-type="bibr" rid="IJSA-12-005C42">42</xref>
            </sup>
         </p>
         <p>Though Kenya has a generalized epidemic, the estimated proportion attributable to MSM suggests that HIV infection among MSM in Kenya is emerging as a significant contributor. Sanders <italic>et al.</italic>
            <sup>
               <xref ref-type="bibr" rid="IJSA-12-005C15">15</xref>
            </sup> recently reported an HIV prevalence of 43.0% among exclusive MSM and 12.3% among men who have sex with men and women, highlighted the vulnerability of these populations. It is important to note that the projections in this study also rely on available epidemiological and behavioural data of MSM; in a stigmatizing environment that currently exists for MSM in Africa, data are particularly difficult to obtain and, thus, these projections may underestimate the attributable fraction and the potential impacts of HIV interventions for MSM. Addressing this HIV epidemic among MSM at an early stage may contribute to reductions in incidence for this particularly hidden group.</p>
         <p>The role of injecting drug use in the HIV epidemic cannot be ignored, and IDU may face both parenteral and sexual risk exposures. Ukraine, with an estimated HIV prevalence of 1.1% among the adult population (2010), now has the greatest prevalence of HIV in Eastern Europe Central Asia<sup>
               <xref ref-type="bibr" rid="IJSA-12-005C43">43</xref>
            </sup> and effective strategies for HIV prevention among the general population and at-risk groups are needed. Strathdee <italic>et al.</italic>
            <sup>
               <xref ref-type="bibr" rid="IJSA-12-005C44">44</xref>
            </sup> estimated that the risk of HIV infection attributable to unprotected sex among IDUs ranged from 15% to 45% in Odessa, Ukraine. This estimate, however, is based on heterosexual transmission and more data are needed to understand the roles and interactions among IDU and MSM. Our projections take into consideration the overlapping sexual and parenteral risks among MSM-IDU. The projections demonstrate the impact of MSM risk reduction interventions on this population, as a subgroup of the MSM population, and highlight the importance of MSM interventions to also access other networked risk group and suggest that, in a similar manner, interventions targeted for IDU may also impact a portion of the MSM population. These findings agree upon the need for developing strategies that effectively target and prevent HIV transmission among at-risk populations.</p>
         <p>Critical to effectively decreasing transmission of HIV among MSM and the general population in all countries is enabling full access to ART for HIV positive MSM. Since the HPTN 052 results reported by Cohen <italic>et al.</italic>
            <sup>
               <xref ref-type="bibr" rid="IJSA-12-005C7">7</xref>
            </sup> have confirmed observational study findings, the importance of ART as prevention further supports the modelling projections reported here. The impacts observed with expansion of ART, however, should not be interpreted as an argument for expanding ART only; rather, the synergies of ART expansion in combination with MSM interventions are important. MSM interventions, particularly outreach, are a method to access hidden MSM, or MSM-IDU, populations for HIV counselling and testing and linkage to ART care.</p>
         <p>Both assets and methodological challenges are associated with the Goals model, as highlighted by a recent assessment of mathematical models to evaluate health programmes.<sup>
               <xref ref-type="bibr" rid="IJSA-12-005C45">45</xref>
            </sup> While Goals is unique in its ability to project impacts based on varying coverage rates, it assumes that the intervention effects are additive and does not currently accommodate interaction effects. This is acceptable if there is agreement that the interaction effects are multiplicative (because then the model estimates would be lower bound estimates of the true impact); but may be problematic if interventions have synergistic effects. A key component of the Goals model is an impact matrix that indicates how behavioural changes when a group of people are exposed to specific prevention interventions. We did not include oral chemoprophylaxis with Truvada, as this intervention has only been tested in a single randomized control trial at the time of writing; however, given recent results,<sup>
               <xref ref-type="bibr" rid="IJSA-12-005C46">46</xref>
            </sup> further analysis is warranted to understand this use and its impact on general and at-risk populations. As the Goals model continues to be refined, estimates of impact should be updated and efforts to validate the projections should be made. As with any model, these projections rely on data availability and quality, and is particularly challenging where underreporting may occur due to pervasive stigma towards MSM. This work may be subject to reporting and publication bias.</p>
         <p>Finally, more understanding of the costs associated with such interventions are required before policy-makers can make informed decisions, particularly as LMICs are often faced with limited financial resources and have to make difficult decisions about how to spend these resources among competing priorities.</p>
         <p>Taken together, our findings suggest that responding to HIV among MSM is an important aspect of overall country-level responses, and this is true across diverse epidemic scenarios. Whether such levels can be achieved is a question of commitment, political will, and a willingness to provide resources for MSM. Continuing to provide current inadequate levels of services to these men will mean that HIV epidemic control will be difficult or impossible to achieve.</p>
      </sec>
   </body>
   <back>
      <ref-list>
         <title>REFERENCES</title>
         <ref id="IJSA-12-005C1">
            <label>1</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Baral</surname>
                  <given-names>S</given-names>
               </name>, <name name-style="western">
                  <surname>Sifakis</surname>
                  <given-names>F</given-names>
               </name>, <name name-style="western">
                  <surname>Cleghorn</surname>
                  <given-names>F</given-names>
               </name>, <name name-style="western">
                  <surname>Beyrer</surname>
                  <given-names>C</given-names>
               </name>. <article-title>Elevated risk for HIV infection among men who have sex with men in low and middle income countries 2000–2006</article-title>. <source>PLoS Med</source>
               <year>2007</year>;<volume>4</volume>:<fpage>e339</fpage>
            </citation>
         </ref>
         <ref id="IJSA-12-005C2">
            <label>2</label>
            <citation citation-type="web" xlink:type="simple">
               <collab xlink:type="simple">International Lesbian Gay Bisexual Trans and Intersex Association</collab>. <italic>Map: Male-to-Male Relationship, Punishments 2010.</italic>
               <year>2010</year>. <comment>See <uri xlink:href="http://ilga.org/ilga/en/index.html" xlink:type="simple">http://ilga.org/ilga/en/index.html</uri>
               </comment> (<comment>cited 20 June 2010</comment>)</citation>
         </ref>
         <ref id="IJSA-12-005C3">
            <label>3</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Beyrer</surname>
                  <given-names>C</given-names>
               </name>, <name name-style="western">
                  <surname>Baral</surname>
                  <given-names>S</given-names>
               </name>, <name name-style="western">
                  <surname>Walker</surname>
                  <given-names>D</given-names>
               </name>, <name name-style="western">
                  <surname>Wirtz</surname>
                  <given-names>A</given-names>
               </name>, <name name-style="western">
                  <surname>Johns</surname>
                  <given-names>B</given-names>
               </name>, <name name-style="western">
                  <surname>Sifakis</surname>
                  <given-names>F</given-names>
               </name>. <article-title>The expanding epidemics of HIV-1 among men who have sex with men in low and middle income countries: diversity and consistency</article-title>. <source>Epidemiol Rev</source>
               <year>2010</year>;<volume>32</volume>:<fpage>137</fpage>–<lpage>51</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-005C4">
            <label>4</label>
            <citation citation-type="book" xlink:type="simple">
               <name name-style="western">
                  <surname>Stover</surname>
                  <given-names>J</given-names>
               </name>, <name name-style="western">
                  <surname>Bollinger</surname>
                  <given-names>L</given-names>
               </name>, <name name-style="western">
                  <surname>Cooper-Arnold</surname>
                  <given-names>K</given-names>
               </name>, <collab xlink:type="simple">The Futures Group International</collab>. <source>Goals Model: For estimating the Effects of Resource Allocation Decisions on the Achievement of the Goals of the HIV/AIDS Strategic Plan</source>. <publisher-loc>Glastonbury, CT</publisher-loc>: <publisher-name>SAGE Publications</publisher-name>, <year>2003</year>
            </citation>
         </ref>
         <ref id="IJSA-12-005C5">
            <label>5</label>
            <citation citation-type="other" xlink:type="simple">
               <collab xlink:type="simple">Futures Institute</collab>. <comment>Goals manual: a model for estimating the effects of interventions and resource allocation on HIV infections and deaths</comment>. <publisher-loc>Glastonbury, CT</publisher-loc>, <year>2011</year>
            </citation>
         </ref>
         <ref id="IJSA-12-005C6">
            <label>6</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Johnson</surname>
                  <given-names>W</given-names>
               </name>, <name name-style="western">
                  <surname>Diaz</surname>
                  <given-names>R</given-names>
               </name>, <name name-style="western">
                  <surname>Flanders</surname>
                  <given-names>W</given-names>
               </name>, <etal/>
               <article-title>Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men</article-title>. <source>Cochrane Database Syst Rev</source>
               <year>2008</year>;<volume>3</volume>:<fpage>CD001230</fpage>
            </citation>
         </ref>
         <ref id="IJSA-12-005C7">
            <label>7</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Cohen</surname>
                  <given-names>MS</given-names>
               </name>, <name name-style="western">
                  <surname>Chen</surname>
                  <given-names>YQ</given-names>
               </name>, <name name-style="western">
                  <surname>McCauley</surname>
                  <given-names>M</given-names>
               </name>, <etal/>
               <article-title>Prevention of HIV-1 infection with early antiretroviral therapy</article-title>. <source>N Engl J Med</source>
               <year>2011</year>
            </citation>
         </ref>
         <ref id="IJSA-12-005C8">
            <label>8</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Eshleman</surname>
                  <given-names>SH</given-names>
               </name>, <name name-style="western">
                  <surname>Hudelson</surname>
                  <given-names>SE</given-names>
               </name>, <name name-style="western">
                  <surname>Redd</surname>
                  <given-names>AD</given-names>
               </name>, <etal/>
               <article-title>Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial</article-title>. <source>J Infect Dis</source>
               <year>2011</year>;<volume>204</volume>:<fpage>1918</fpage>–<lpage>26</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-005C9">
            <label>9</label>
            <citation citation-type="other" xlink:type="simple">
               <name name-style="western">
                  <surname>Amjadeen</surname>
                  <given-names>L</given-names>
               </name>, <name name-style="western">
                  <surname>Kaschenkova</surname>
                  <given-names>K</given-names>
               </name>, <name name-style="western">
                  <surname>Konoplytska</surname>
                  <given-names>T</given-names>
               </name>, <etal/>
               <comment>Report on the survey “Monitoring behaviours of MSM as a component of second-generation surveillance”. International AIDS Alliance. Kiev</comment>; <year>2005</year>. <comment>Available at: <uri xlink:href="http://www.aidsalliance.org.ua/cgi-bin/index.cgi?url=/en/library/our/index.htm" xlink:type="simple">http://www.aidsalliance.org.ua/cgi-bin/index.cgi?url=/en/library/our/index.htm</uri>
               </comment>
            </citation>
         </ref>
         <ref id="IJSA-12-005C10">
            <label>10</label>
            <citation citation-type="other" xlink:type="simple">
               <name name-style="western">
                  <surname>Balakiryeva</surname>
                  <given-names>O</given-names>
               </name>, <name name-style="western">
                  <surname>Bondar</surname>
                  <given-names>T</given-names>
               </name>, <name name-style="western">
                  <surname>Kasyanczuk</surname>
                  <given-names>M</given-names>
               </name>. <comment>Report on the survey ‘Monitoring behaviours of men having sex with men as a component of second generation surveillance’</comment>. <publisher-loc>Kiev</publisher-loc>: <publisher-name>SAGE Publications</publisher-name>, <year>2008</year>
            </citation>
         </ref>
         <ref id="IJSA-12-005C11">
            <label>11</label>
            <citation citation-type="journal" xlink:type="simple">
               <collab xlink:type="simple">Centers for Disease Control and Prevention (CDC)</collab>. <article-title>HIV prevalence among populations of men who have sex with men – Thailand, 2003 and 2005</article-title>. <source>Morb Mortal Wkly Rep</source>
               <year>2006</year>;<volume>55</volume>:<fpage>844</fpage>–<lpage>8</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-005C12">
            <label>12</label>
            <citation citation-type="other" xlink:type="simple">
               <collab xlink:type="simple">International HIV/AIDS Alliance in Ukraine</collab>. <comment>Monitoring behaviour of men having sex with men: analytical report on the results of the research</comment>. <publisher-loc>Kyiv</publisher-loc>: <publisher-name>SAGE Publications</publisher-name>, <year>2008</year>
            </citation>
         </ref>
         <ref id="IJSA-12-005C13">
            <label>13</label>
            <citation citation-type="other" xlink:type="simple">
               <collab xlink:type="simple">MINSA</collab>. <comment>Estadistica: Indicadores de salud. Ministerio de Salud del Peru</comment>, <year>2009</year>
            </citation>
         </ref>
         <ref id="IJSA-12-005C14">
            <label>14</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Sanchez</surname>
                  <given-names>J</given-names>
               </name>, <name name-style="western">
                  <surname>Lama</surname>
                  <given-names>JR</given-names>
               </name>, <name name-style="western">
                  <surname>Peinado</surname>
                  <given-names>J</given-names>
               </name>, <etal/>
               <article-title>High HIV and ulcerative sexually transmitted infection incidence estimates among men who have sex with men in Peru: awaiting for an effective preventive intervention</article-title>. <source>J Acquir Immune Defic Syndr</source>
               <year>2009</year>;<volume>51</volume>(<supplement>Suppl. 1</supplement>):<fpage>S47</fpage>–<lpage>51</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-005C15">
            <label>15</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Sanders</surname>
                  <given-names>E</given-names>
               </name>, <name name-style="western">
                  <surname>Graham</surname>
                  <given-names>S</given-names>
               </name>, <name name-style="western">
                  <surname>Okuku</surname>
                  <given-names>H</given-names>
               </name>, <etal/>
               <article-title>HIV-1 infection in high risk men who have sex with men in Mombasa, Kenya</article-title>. <source>AIDS</source>
               <year>2007</year>;<volume>21</volume>:<fpage>2513</fpage>–<lpage>20</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-005C16">
            <label>16</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Hierholzer</surname>
                  <given-names>J</given-names>
               </name>, <name name-style="western">
                  <surname>Montano</surname>
                  <given-names>S</given-names>
               </name>, <name name-style="western">
                  <surname>Hoelscher</surname>
                  <given-names>M</given-names>
               </name>, <etal/>
               <article-title>Molecular epidemiology of HIV type 1 in Ecuador, Peru, Bolivia, Uruguay, and Argentina</article-title>. <source>AIDS Res Hum Retroviruses</source>
               <year>2002</year>;<volume>18</volume>:<fpage>1339</fpage>–<lpage>50</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-005C17">
            <label>17</label>
            <citation citation-type="other" xlink:type="simple">
               <name name-style="western">
                  <surname>Angala</surname>
                  <given-names>P</given-names>
               </name>, <name name-style="western">
                  <surname>Parkinson</surname>
                  <given-names>A</given-names>
               </name>, <name name-style="western">
                  <surname>KIlonzo</surname>
                  <given-names>N</given-names>
               </name>, <name name-style="western">
                  <surname>Natecho</surname>
                  <given-names>A</given-names>
               </name>, <name name-style="western">
                  <surname>Taegtmeyer</surname>
                  <given-names>M</given-names>
               </name>. <comment>Men who have sex with men (MSM) as presented in VCT data in Kenya (Abstract no. MOPE0581). AIDS 2006-XVI International AIDS Conference; 2006; Toronto</comment>, <year>2006</year>
            </citation>
         </ref>
         <ref id="IJSA-12-005C18">
            <label>18</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Van Griensven</surname>
                  <given-names>F</given-names>
               </name>, <name name-style="western">
                  <surname>Thanprasertsuk</surname>
                  <given-names>S</given-names>
               </name>, <name name-style="western">
                  <surname>Jommaroeng</surname>
                  <given-names>R</given-names>
               </name>, <etal/>, <collab xlink:type="simple">Bangkok MSM Study Group</collab>. <article-title>Evidence of a previously undocumented epidemic of HIV infection among men who have sex with men in Bangkok, Thailand</article-title>. <source>AIDS</source>
               <year>2005</year>;<volume>19</volume>:<fpage>521</fpage>–<lpage>6</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-005C19">
            <label>19</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>van Griensven</surname>
                  <given-names>F</given-names>
               </name>, <name name-style="western">
                  <surname>Varangrat</surname>
                  <given-names>A</given-names>
               </name>, <name name-style="western">
                  <surname>Wimonsate</surname>
                  <given-names>W</given-names>
               </name>, <etal/>
               <article-title>Trends in HIV prevalence, estimated HIV incidence, and risk behavior among men who have sex with men in Bangkok, Thailand, 2003–2007</article-title>. <source>J Acquir Immune Defic Syndr</source>
               <year>2009</year>
            </citation>
         </ref>
         <ref id="IJSA-12-005C20">
            <label>20</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Aldridge</surname>
                  <given-names>RW</given-names>
               </name>, <name name-style="western">
                  <surname>Iglesias</surname>
                  <given-names>D</given-names>
               </name>, <name name-style="western">
                  <surname>Caceres</surname>
                  <given-names>CF</given-names>
               </name>, <name name-style="western">
                  <surname>Miranda</surname>
                  <given-names>JJ</given-names>
               </name>. <article-title>Determining a cost effective intervention response to HIV/AIDS in Peru</article-title>. <source>BMC Public Health</source>
               <year>2009</year>;<volume>9</volume>:<fpage>352</fpage>
            </citation>
         </ref>
         <ref id="IJSA-12-005C21">
            <label>21</label>
            <citation citation-type="other" xlink:type="simple">
               <collab xlink:type="simple">UNAIDS, Ministry of Health of Ukraine</collab>. <comment>Ukraine: National report on monitoring progress toward the UNGASS Declaration of Commitment on HIV/AIDS. Reporting period: January 2006–December 2007. Kiev</comment>, <year>2008</year>
            </citation>
         </ref>
         <ref id="IJSA-12-005C22">
            <label>22</label>
            <citation citation-type="other" xlink:type="simple">
               <collab xlink:type="simple">International HIV/AIDS Alliance in Ukraine</collab>. <comment>Analytical report: estimation of the size of populations most-at-risk for HIV infection in ukraine in 2009</comment>. <publisher-loc>Kyiv</publisher-loc>: <publisher-name>SAGE Publications</publisher-name>, <year>2010</year>
            </citation>
         </ref>
         <ref id="IJSA-12-005C23">
            <label>23</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Kruglov</surname>
                  <given-names>Y</given-names>
               </name>, <name name-style="western">
                  <surname>Kobyshcha</surname>
                  <given-names>Y</given-names>
               </name>, <name name-style="western">
                  <surname>Salyuk</surname>
                  <given-names>T</given-names>
               </name>. <article-title>The most severe HIV epidemic in Europe: Ukraine's national HIV prevalence estimates for 2007</article-title>. <source>Sex Transm Infect</source>
               <year>2008</year>;<volume>84</volume>(<supplement>Suppl. 1</supplement>):<fpage>i37</fpage>–<lpage>41</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-005C24">
            <label>24</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Baral</surname>
                  <given-names>S</given-names>
               </name>, <name name-style="western">
                  <surname>Kizub</surname>
                  <given-names>D</given-names>
               </name>, <name name-style="western">
                  <surname>Masenior</surname>
                  <given-names>NF</given-names>
               </name>, <etal/>
               <article-title>Male sex workers in Moscow, Russia: a pilot study of demographics, substance use patterns, and prevalence of HIV-1 and sexually transmitted infections</article-title>. <source>AIDS Care</source>
               <year>2010</year>;<volume>22</volume>(<issue>1</issue>):<fpage>112</fpage>–<lpage>8</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-005C25">
            <label>25</label>
            <citation citation-type="other" xlink:type="simple">
               <collab xlink:type="simple">WHO Regional Office for Europe</collab>. <comment>HIV prevalence and risks among men who have sex with men in Moscow and Saint Petersburg. Copenhagen</comment>, <year>2007</year>
            </citation>
         </ref>
         <ref id="IJSA-12-005C26">
            <label>26</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Amirkhanian</surname>
                  <given-names>YA</given-names>
               </name>, <name name-style="western">
                  <surname>Kelly</surname>
                  <given-names>JA</given-names>
               </name>, <name name-style="western">
                  <surname>Issayev</surname>
                  <given-names>DD</given-names>
               </name>. <article-title>AIDS knowledge, attitudes, and behaviour in Russia: results of a population-based, random-digit telephone survey in St Petersburg</article-title>. <source>Int J STD AIDS</source>
               <year>2001</year>;<volume>12</volume>:<fpage>50</fpage>–<lpage>7</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-005C27">
            <label>27</label>
            <citation citation-type="other" xlink:type="simple">
               <name name-style="western">
                  <surname>Sifakis</surname>
                  <given-names>F</given-names>
               </name>, <name name-style="western">
                  <surname>Peryskina</surname>
                  <given-names>A</given-names>
               </name>, <name name-style="western">
                  <surname>Sergeev</surname>
                  <given-names>B</given-names>
               </name>. <comment>Rapid Assessment of HIV infection and associated risk behaviors among men who have sex with men in Russia. [Abstract MOPE0396]. XVII International AIDS Conference</comment>. <publisher-loc>Mexico City, Mexico</publisher-loc>, <year>2008</year>
            </citation>
         </ref>
         <ref id="IJSA-12-005C28">
            <label>28</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Kelly</surname>
                  <given-names>JA</given-names>
               </name>, <name name-style="western">
                  <surname>Amirkhanian</surname>
                  <given-names>YA</given-names>
               </name>, <name name-style="western">
                  <surname>McAuliffe</surname>
                  <given-names>TL</given-names>
               </name>, <etal/>
               <article-title>HIV risk characteristics and prevention needs in a community sample of bisexual men in St. Petersburg, Russia</article-title>. <source>AIDS Care</source>
               <year>2002</year>;<volume>14</volume>:<fpage>63</fpage>–<lpage>76</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-005C29">
            <label>29</label>
            <citation citation-type="other" xlink:type="simple">
               <collab xlink:type="simple">PSI Russia</collab>. <comment>HIV/AIDS TRaC Study of Risk, Health-seeking Behaviors, and Their Determinants, Among Men Who Have Sex with Men in Eight Regions of the Russian Federation. Second Round</comment>. <publisher-loc>Moscow</publisher-loc>: <publisher-name>SAGE Publications</publisher-name>, <year>2008</year>
            </citation>
         </ref>
         <ref id="IJSA-12-005C30">
            <label>30</label>
            <citation citation-type="other" xlink:type="simple">
               <name name-style="western">
                  <surname>Tyusova</surname>
                  <given-names>O</given-names>
               </name>, <name name-style="western">
                  <surname>Verevochkin</surname>
                  <given-names>S</given-names>
               </name>, <name name-style="western">
                  <surname>Heimer</surname>
                  <given-names>R</given-names>
               </name>. <comment>HIV in population groups recruited by respondent-driven sampling in St. Petersburg. [Abstract]. III Eastern Europe and Central Asia AIDS Conference</comment>. <publisher-loc>Moscow, Russia</publisher-loc>, <year>2009</year>
            </citation>
         </ref>
         <ref id="IJSA-12-005C31">
            <label>31</label>
            <citation citation-type="other" xlink:type="simple">
               <name name-style="western">
                  <surname>Onyango-Ouma</surname>
                  <given-names>W</given-names>
               </name>, <name name-style="western">
                  <surname>Birungi</surname>
                  <given-names>H</given-names>
               </name>, <name name-style="western">
                  <surname>Geibel</surname>
                  <given-names>S</given-names>
               </name>. <comment>Understanding the HIV/STI Risks and prevention needs of men who have sex with men in Nairobi, Kenya</comment>. <publisher-loc>Nairobi</publisher-loc>, <year>2005</year>
            </citation>
         </ref>
         <ref id="IJSA-12-005C32">
            <label>32</label>
            <citation citation-type="other" xlink:type="simple">
               <name name-style="western">
                  <surname>Ugarte Ubilluz</surname>
                  <given-names>O</given-names>
               </name>, <name name-style="western">
                  <surname>Arce Rodriguez</surname>
                  <given-names>M</given-names>
               </name>, <name name-style="western">
                  <surname>Acosta Saal</surname>
                  <given-names>C</given-names>
               </name>, <name name-style="western">
                  <surname>Suarez Ognio</surname>
                  <given-names>L</given-names>
               </name>. <comment>Informe nacional sobre los progresos realizados en la aplicacion del ungass periodo: Enero 2008 - Diciembre 2009. Lima, 2010 30 Marzo</comment>
            </citation>
         </ref>
         <ref id="IJSA-12-005C33">
            <label>33</label>
            <citation citation-type="other" xlink:type="simple">
               <collab xlink:type="simple">UNAIDS, WHO</collab>. <comment>Epidemiological fact sheets on HIV and AIDS, 2008 Update – Peru. Report. Geneva: UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance, 2008 December 2008</comment>
            </citation>
         </ref>
         <ref id="IJSA-12-005C34">
            <label>34</label>
            <citation citation-type="other" xlink:type="simple">
               <collab xlink:type="simple">Family Health International, Bureau of AIDS TB and STIs, Department of Disease Control MOPH Thailand</collab>. <comment>The Asian Epidemic Model (AEM) Projections for HIV/AIDS in Thailand: 2005–2025: The Thai Working Group on HIV/AIDS Projections (2005)</comment>, <year>2008</year>
            </citation>
         </ref>
         <ref id="IJSA-12-005C35">
            <label>35</label>
            <citation citation-type="other" xlink:type="simple">
               <name name-style="western">
                  <surname>Wimonsate</surname>
                  <given-names>W</given-names>
               </name>, <name name-style="western">
                  <surname>Chaikummao</surname>
                  <given-names>S</given-names>
               </name>, <name name-style="western">
                  <surname>Tongtoyai</surname>
                  <given-names>J</given-names>
               </name>, <name name-style="western">
                  <surname>Kittinunvorakoon</surname>
                  <given-names>C</given-names>
               </name>, <name name-style="western">
                  <surname>Sriporn</surname>
                  <given-names>A</given-names>
               </name>, <name name-style="western">
                  <surname>Varangrat</surname>
                  <given-names>A</given-names>
               </name>. <comment>Successful start of a preparatory HIV cohort study among men who have sex with men (MSM) in Bangkok, Thailand: preliminary baseline, follow-up and HIV incidence data (Abstract MOAC0105). XVII International AIDS Conference Mexico City</comment>, <year>2008</year>
            </citation>
         </ref>
         <ref id="IJSA-12-005C36">
            <label>36</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Beyrer</surname>
                  <given-names>C</given-names>
               </name>, <name name-style="western">
                  <surname>Sripaipan</surname>
                  <given-names>T</given-names>
               </name>, <name name-style="western">
                  <surname>Tovanabutra</surname>
                  <given-names>S</given-names>
               </name>, <etal/>
               <article-title>High HIV, hepatitis C and sexual risks among drug-using men who have sex with men in northern Thailand</article-title>. <source>AIDS</source>
               <year>2005</year>;<volume>19</volume>:<fpage>1535</fpage>–<lpage>40</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-005C37">
            <label>37</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Kunawararak</surname>
                  <given-names>P</given-names>
               </name>, <name name-style="western">
                  <surname>Beyrer</surname>
                  <given-names>C</given-names>
               </name>, <name name-style="western">
                  <surname>Natpratan</surname>
                  <given-names>C</given-names>
               </name>, <etal/>
               <article-title>The epidemiology of HIV and syphilis among male commercial sex workers in northern Thailand</article-title>. <source>AIDS</source>
               <year>1995</year>;<volume>9</volume>:<fpage>517</fpage>–<lpage>21</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-005C38">
            <label>38</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Chariyalertsak</surname>
                  <given-names>S</given-names>
               </name>, <name name-style="western">
                  <surname>Kosachunhanan</surname>
                  <given-names>N</given-names>
               </name>, <name name-style="western">
                  <surname>Saokhieo</surname>
                  <given-names>P</given-names>
               </name>, <etal/>
               <article-title>HIV incidence, risk factors, and motivation for biomedical intervention among gay, bisexual men, and transgender persons in Northern Thailand</article-title>. <source>PLoS One</source>
               <year>2011</year>;<volume>6</volume>:<fpage>e24295</fpage>
            </citation>
         </ref>
         <ref id="IJSA-12-005C39">
            <label>39</label>
            <citation citation-type="other" xlink:type="simple">
               <collab xlink:type="simple">National AIDS Prevention and Alleviation Committee (Thailand)</collab>. <comment>UNGASS Country Progress Report: Thailand (Period January 2008- December 2009). Bangkok: National AIDS Prevention and Alleviation Committee</comment>, <year>2010</year>
            </citation>
         </ref>
         <ref id="IJSA-12-005C40">
            <label>40</label>
            <citation citation-type="other" xlink:type="simple">
               <collab xlink:type="simple">WHO</collab>. <comment>Antiretroviral therapy for HIV infection in adults and adolescents: 2010 revision. Geneva</comment>, <year>2010</year>
            </citation>
         </ref>
         <ref id="IJSA-12-005C41">
            <label>41</label>
            <citation citation-type="book" xlink:type="simple">
               <name name-style="western">
                  <surname>Beyrer</surname>
                  <given-names>C</given-names>
               </name>, <name name-style="western">
                  <surname>Wirtz</surname>
                  <given-names>A</given-names>
               </name>, <name name-style="western">
                  <surname>Walker</surname>
                  <given-names>D</given-names>
               </name>, <name name-style="western">
                  <surname>Johns</surname>
                  <given-names>B</given-names>
               </name>, <name name-style="western">
                  <surname>Sifakis</surname>
                  <given-names>F</given-names>
               </name>, <name name-style="western">
                  <surname>Baral</surname>
                  <given-names>S</given-names>
               </name>. <source>The global HIV epidemics among men who have sex with men</source>. <publisher-loc>Washington, DC</publisher-loc>, <year>2011</year>. <comment>The World Bank. Available at: <uri xlink:href="http://siteresources.worldbank.org/INTHIVAIDS/Resources/375798-1103037153392/MSMReport.pdf" xlink:type="simple">http://siteresources.worldbank.org/INTHIVAIDS/Resources/375798-1103037153392/MSMReport.pdf</uri>
               </comment>
            </citation>
         </ref>
         <ref id="IJSA-12-005C42">
            <label>42</label>
            <citation citation-type="other" xlink:type="simple">
               <name name-style="western">
                  <surname>Caceres</surname>
                  <given-names>C</given-names>
               </name>, <name name-style="western">
                  <surname>de Zalduondo</surname>
                  <given-names>B</given-names>
               </name>, <name name-style="western">
                  <surname>Hallett</surname>
                  <given-names>T</given-names>
               </name>, <name name-style="western">
                  <surname>Avila</surname>
                  <given-names>C</given-names>
               </name>, <name name-style="western">
                  <surname>Clayton</surname>
                  <given-names>M</given-names>
               </name>. <comment>Combination HIV prevention: Crafting a new standard for the long-term response to HIV. International AIDS Conference; 2010 July 2010</comment>; <publisher-loc>Vienna</publisher-loc>, <year>2010</year>
            </citation>
         </ref>
         <ref id="IJSA-12-005C43">
            <label>43</label>
            <citation citation-type="other" xlink:type="simple">
               <collab xlink:type="simple">UNAIDS</collab>. <comment>UNAIDS Report on the Global AIDS Epidemic: 2010</comment>. <publisher-loc>Geneva</publisher-loc>, <year>2010</year>
            </citation>
         </ref>
         <ref id="IJSA-12-005C44">
            <label>44</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Strathdee</surname>
                  <given-names>S</given-names>
               </name>, <name name-style="western">
                  <surname>Hallett</surname>
                  <given-names>T</given-names>
               </name>, <name name-style="western">
                  <surname>Bobrova</surname>
                  <given-names>N</given-names>
               </name>, <etal/>
               <article-title>HIV and risk environment for injecting drug users: the past, present, and future</article-title>. <source>Lancet</source>
               <year>2010</year>;<volume>376</volume>:<fpage>268</fpage>–<lpage>84</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-005C45">
            <label>45</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Garnett</surname>
                  <given-names>GP</given-names>
               </name>, <name name-style="western">
                  <surname>Cousens</surname>
                  <given-names>S</given-names>
               </name>, <name name-style="western">
                  <surname>Hallett</surname>
                  <given-names>TB</given-names>
               </name>, <name name-style="western">
                  <surname>Steketee</surname>
                  <given-names>R</given-names>
               </name>, <name name-style="western">
                  <surname>Walker</surname>
                  <given-names>N</given-names>
               </name>. <article-title>Mathematical models in the evaluation of health programmes</article-title>. <source>Lancet</source>
               <year>2011</year>;<volume>378</volume>:<fpage>515</fpage>–<lpage>25</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-005C46">
            <label>46</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Grant</surname>
                  <given-names>R</given-names>
               </name>, <name name-style="western">
                  <surname>Lama</surname>
                  <given-names>J</given-names>
               </name>, <name name-style="western">
                  <surname>Anderson</surname>
                  <given-names>P</given-names>
               </name>, <etal/>
               <article-title>Preexposure chemoprophylaxis for HIV prevention in men who have sex with men</article-title>. <source>N Engl J Med</source>
               <year>2010</year>;<volume>363</volume>:<fpage>2587</fpage>–<lpage>99</lpage>
            </citation>
         </ref>
         <ref id="IJSA-12-005C47">
            <label>47</label>
            <citation citation-type="journal" xlink:type="simple">
               <name name-style="western">
                  <surname>Bollinger</surname>
                  <given-names>LA</given-names>
               </name>. <article-title>How can we calculate the ‘E’ in ‘CEA’?</article-title>
               <source>AIDS</source>
               <year>2008</year>;<volume>22</volume>(<supplement>Suppl. 1</supplement>):<fpage>S51</fpage>–<lpage>7</lpage>
            </citation>
         </ref>
      </ref-list>
      <app-group>
         <app>
            <title>Appendix</title>
            <sec id="s5">
               <title>Goals model description</title>
               <sec id="s5a">
                  <title>Overview</title>
                  <p>The Goals model was developed to estimate the national impacts of programmatic and budgetary decisions on HIV incidence and the achievement of HIV/AIDS programs’ goals. The Goals model was applied here to investigate the effect on men who have sex with men (MSM) and adult infections with expansion of targeted interventions for MSM and combinations of these interventions with antiretroviral therapy (ART) expansion among the general population.</p>
                  <p>The Goals model is a deterministic model, integrated within the Spectrum suite of models/tools as a ‘module’, which uses demographic, behavioural and epidemiological data to project HIV prevalence and incidence. Each country model utilizes its own specific inputs and inputs are further specified to the defined risk groups. The Goals model uses population-level demographic and epidemic projections from other Spectrum modules, such as the AIDS Impact Model (AIM) and DemProj (population) and AIM is populated with each country's national ART strategy.</p>
               </sec>
               <sec id="s5b">
                  <title>Risk groups</title>
                  <p>The Goals model simulates an HIV epidemic in an adult population aged 15–49. The adult population is disaggregated by sex and risk group. People enter the model at age 15 and are assumed to not be sexually active until they reach the median age at first sex, a value that is specified for each country. The focus is on this population because most new infections occur in this age group and most survey data on sexual behaviour refer to this age group.</p>
                  <p>The population risk groups within Goals risk groups are defined by sexual or drug-use behaviours and are divided into: low-, medium- and high-risk heterosexuals of both genders (high risk often pertains to female sex workers and their clients), people who inject drugs (both genders) and MSM. For the purposes of this exercise, we further developed the Goals model to include low, medium, and high MSM risk groups, as well as MSM who inject drugs (MSM-IDU). The Goals model can now be specified to allow for a single MSM category or four MSM categories. Once a person joins a risk group he or she remains in that risk group until any of the following occurs: the person ages out at age 50, dies from non-AIDS cases, dies from AIDS-related causes or changes behaviour. Behavioural change allows people to move from one risk group to a lower risk group and this is based on the specified duration in a risk group. For example, duration in sex work is often set to 5 or 10 years. For the purposes of this study, we do not assume any duration for time in any MSM category, other than MSM-IDU. Those leaving the highest risk groups (sex work or IDU) move to the medium heterosexual risk group (casual sex) and those leaving the casual sex group move to the stable couples risk group. Figure <xref ref-type="fig" rid="IJSA-12-005F7">1A</xref>, depicts the model risk structure in Goals.
<fig id="IJSA-12-005F7" position="float">
                        <label>Appendix Figure 1A</label>
                        <caption>
                           <p>Goals model risk structure</p>
                        </caption>
                        <graphic position="float" xlink:href="10.1177_0956462412472291-app1.tif" xlink:type="simple"/>
                     </fig>
                  </p>
                  <p>Though this study does not focus on other risk groups such as female sex workers or people who inject drugs, the inclusion of these groups in the developed country models ensures that the variety of behaviours, HIV and STI prevalence, and differential risk observed in each modelled country is properly assessed. Risk group parameters are obtained and incorporated into the model through additional research, communication with country or risk group experts.</p>
                  <p>Within Goals, behavioural parameters, such as numbers of partners, condom use, etc. are edited according to research or surveillance data that are available. Specific inputs for each risk group can be manually specified and are typically obtained through published scientific research, national biobehavioural surveillance estimates, UNAIDS reports and other unpublished data. Baseline intervention coverage levels of behavioural interventions are estimated based on country-level reporting or expert input, presented as percentages. Goals then projects the number of new infections according to changes in interventions which effect changes to behaviours, and thus risk for HIV transmission. Change in coverage of an intervention is mapped to a change in the behaviour of those risk groups reached by the intervention, ultimately changing risk behaviour and the number of new infections. Depending on intervention effect, the risk group reached and associated behaviours, some interventions therefore have wider impact than others.</p>
               </sec>
               <sec id="s5c">
                  <title>Transmission of HIV</title>
                  <p>Transmission of HIV from an infected partner to an uninfected partner depends on the characteristics of both partners and the partnership. For the susceptible partner the important characteristics are the number of partners and whether or not new prevention methods, such as PrEP or vaccines, are used. This study did not incorporate the use of PrEP or vaccines. Transmission from the infected partner is affected by the stage of infection (primary, asymptomatic or symptomatic) and whether the partner is receiving ART. Characteristics of the partnership that influence transmission are the number of acts per partner per year, whether either partner has a sexually transmitted infection, the type of contact (vaginal or anal sexual intercourse or needle sharing) and condom use.</p>
                  <p>New infections, <italic>I,</italic> are calculated as the susceptible population, <italic>X</italic>, multiplied by the probability of becoming infected, ι:
<disp-formula>
                        <graphic position="float" xlink:href="10.1177_0956462412472291-eq1.tif" xlink:type="simple"/>
                     </disp-formula>where <italic>s</italic> = sex, male or female; <italic>k</italic> = risk group and <italic>t</italic> = time.</p>
                  <p>The probability of transmission to an uninfected partner during one year, ι, is given by the equation below:
<disp-formula>
                        <graphic position="float" xlink:href="10.1177_0956462412472291-eq2.tif" xlink:type="simple"/>
                     </disp-formula>where <italic>P<sub>s′,k,t</sub>
                     </italic> = HIV prevalence in the partner population of risk group <italic>k</italic> at time <italic>t</italic>; <italic>r</italic> = base probability of HIV transmission per act; <italic>R<sub>t</sub>
                     </italic> = multiplier for the effect of stage of infection; <italic>C<sub>k,t</sub>
                     </italic> = multiplier for effect of condom use; MC<italic>
                        <sub>k,t</sub>
                     </italic> = multiplier for effect of male circumcision; <italic>S<sub>k,t</sub>
                     </italic> = multiplier for effect of sexually transmitted infections; Pr<italic>
                        <sub>k,t</sub>
                     </italic> = multiplier for effect of PrEP; <italic>V<sub>k,t</sub>
                     </italic> = multiplier for effect of HIV vaccines; <italic>a</italic> = number of acts per partner per year and <italic>n</italic> = number of partners per year.</p>
                  <p>Prevalence in the partner population is defined differently for each risk group. For sex workers or clients and those with multiple partners, it is the prevalence of the population of the opposite sex in the same risk group. For MSM it is the prevalence in the MSM group. For stable couples the prevalence in the partner population is a weighted average of the prevalence in each risk group <italic>P</italic> multiplied by the proportion of contacts with that risk group <italic>A</italic>.
<disp-formula>
                        <graphic position="float" xlink:href="10.1177_0956462412472291-eq3.tif" xlink:type="simple"/>
                     </disp-formula>For those in stable relationships the proportion of contacts with each risk group is calculated from the number of people in each risk group <italic>N<sub>k</sub>
                     </italic> and the proportion married <italic>m</italic>.
<disp-formula>
                        <graphic position="float" xlink:href="10.1177_0956462412472291-eq4.tif" xlink:type="simple"/>
                     </disp-formula>The effect of stage of infection is calculated as a weighted average of infectiousness by stage <italic>i</italic> and the proportion of the population in each stage. Disease stages are primary infection, asymptomatic, symptomatic (CD4 count &lt;200 cells/μL) and on ART.
<disp-formula>
                        <graphic position="float" xlink:href="10.1177_0956462412472291-eq5.tif" xlink:type="simple"/>
                     </disp-formula>where <italic>Y<sub>i,k,s,t</sub>
                     </italic> = HIV + population in stage <italic>i</italic> risk group <italic>k</italic> sex <italic>s</italic> at time <italic>t</italic> and IM<italic>
                        <sub>i</sub>
                     </italic> = infectiousness multiplier of stage <italic>i.</italic>
                  </p>
                  <p>The impact of sexually transmitted infections (STIs) is calculated from the prevalence of STIs in either partner and the increase in transmission when STIs are present.
<disp-formula>
                        <graphic position="float" xlink:href="10.1177_0956462412472291-eq6.tif" xlink:type="simple"/>
                     </disp-formula>where Sm = multiplier on the probability of transmission when either partner has an STI and Sp<italic>
                        <sub>k,t</sub>
                     </italic> = proportion of risk group <italic>k</italic> with an STI at time <italic>t.</italic>
                  </p>
                  <p>The probability of transmission through drug injections is determined by a force of infection variable that expresses the rate of contact between sharing groups <italic>f</italic>, the prevalence of HIV among IDU <italic>P</italic>, the multiplier for stage of infection <italic>R</italic> and any effects of new technologies such as vaccines <italic>V</italic> or PrEP <italic>Pr</italic>.
<disp-formula>
                        <graphic position="float" xlink:href="10.1177_0956462412472291-eq7.tif" xlink:type="simple"/>
                     </disp-formula>The impacts of behavioural interventions is calculated using the transmission equation and variables for condom use, Cc<italic>,</italic> and the number of partners, <italic>n</italic>. Though not assessed for this study, behavioural change interventions may also affect age at first sex and needle sharing among IDUs, which determined the proportion of injecting drug users who are susceptible to infection.</p>
                  <p>The impact of interventions on each of these behaviours is determined by an impact matrix that describes the impact of each intervention on each behaviour for each risk group. The impact matrix is based on an extensive literature search<sup>
                        <xref ref-type="bibr" rid="IJSA-12-005C47">47</xref>
                     </sup> and prepopulated in the Goals model of the Spectrum suite. It is not specific to any particular country. This study further updated the Goals impact matrix for MSM; these inputs are also based on an extensive literature review<sup>
                        <xref ref-type="bibr" rid="IJSA-12-005C41">41</xref>
                     </sup> and these values are provided in Table 4.</p>
                  <p>The impact for condom use is calculated as a reduction in the non-use of condoms in order to allow for the aggregation of impacts when several interventions are present. Thus, condom use is calculated as one minus the non-use of condoms in the base year multiplied by the product across all interventions of the increase in coverage of each intervention and it impact on condom non-use:
<disp-formula>
                        <graphic position="float" xlink:href="10.1177_0956462412472291-eq8.tif" xlink:type="simple"/>
                     </disp-formula>
                  </p>
                  <p>The impact on the number of sexual partners is determined as the number of partner in the base year multiplied by the product of the increase in coverage and the impact of each intervention.
<disp-formula>
                        <graphic position="float" xlink:href="10.1177_0956462412472291-eq9.tif" xlink:type="simple"/>
                     </disp-formula>
                  </p>
                  <p>Calculations for other impacts may be found in the Goals manual.<sup>
                        <xref ref-type="bibr" rid="IJSA-12-005C5">5</xref>
                     </sup>
                  </p>
               </sec>
               <sec id="s5d">
                  <title>ART allocation</title>
                  <p>The model structure has seven CD4 compartments with specific eligibility criteria and mortality patterns. CD4 count is the determining factor for several HIV parameters: progression to lower CD4 counts, HIV-related mortality, probability of initiating ART and infectiousness. ART initiation may be specified and, for the purposes of this study was selected to initiate at CD4 &lt;350 cells/μL, based on recent findings<sup>
                        <xref ref-type="bibr" rid="IJSA-12-005C8">8</xref>
                     </sup> and WHO guidelines.<sup>
                        <xref ref-type="bibr" rid="IJSA-12-005C40">40</xref>
                     </sup> The probability of HIV-related death, but also ART enrollment, increases as CD4 counts decrease. An assumption is made that most newly infected people start with CD4 counts above 500 CD4 cells/μL, although some portion, <italic>p,</italic> can start at 350–499 CD4 cells/μL.</p>
                  <p>The number of people on ART in each year is an input into Spectrum/AIM. It is used to determine the number of people newly starting ART in each year in order to achieve the specified number of patients. Loss to follow up is indirectly captured by maintaining a specified number of coverage of those on treatment. New ART patients are allocated according to two equally weighted criteria: the same proportion of patients from each eligible CD4 category are started on ART, and new ART patients are allocated on the basis of expected HIV-related mortality without ART. Further details on ART allocation and other key parameter values may be found in the Goals manual.<sup>
                        <xref ref-type="bibr" rid="IJSA-12-005C5">5</xref>
                     </sup>
                  </p>
               </sec>
            </sec>
         </app>
      </app-group>
   </back>
</article>